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QUOTATION
“It was the best of times, it was the worst of times, it was the age of wisdom, 
it was the age of foolishness, it was the epoch of belief, it was the epoch of 
incredulity, it was the season of Light, it was the season of Darkness, it was 
the spring of hope, it was the winter of despair, we had everything before us, 
we had nothing before us, we were all going direct to Heaven, we were all 
going direct the other way...”
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ABSTRACT
The present research was performed to characterize immunoreactive (ir) pituitary 
cells in the equine species. Two experiments were performed to measure the prevalence 
of single- and double-hormone labeled gonadotropes, lactotropes, somatotropes, and 
mammosomatotropes. In Experiments 1 and 2, pituitaries from three intact pony mares 
were processed for ultrastructural evaluation of cells stained for luteinizing hormone 
(LH), follicle-stimulating hormone (FSH), prolactin (PRL), and growth hormone (GH). 
Primary antibodies and gold-conjugated antibodies were used to double-stain ir-cells.
The percentages of pituitary cells stained for each hormone in intact mares were; total 
gonadotropes, 15 to 32 %; LH-only, 2 to 16%; FSH-only, 1 to 5%; LH/FSH, 6 to 24%; 
GH-only, 11 to 26%; PRL-only, 5 to 16%; and GH/PRL, 7 to 17%. In Experiments 3 
and 4, long-term ovariectomized (OVX) mares (n = 4/group) were injected with vehicle, 
estradiol (35 pg/kg), or dihydrotestosterone (DHT; 150 pg/kg) for 21 days. 
Immunoreactive-cells were identified immunocytochemically and pituitary content of 
LH, FSH, GH, and PRL and plasma concentrations of LH, FSH, and PRL were 
measured. DHT reduced (P < .05) plasma LH and FSH but had no effect (P > .1) on 
plasma PRL. Estradiol reduced (P < .05) plasma FSH but had no effect (P > .1) on 
plasma LH. The percentages of pituitary cells which stained for each hormone in control 
OVX mares were: total gonadotropes, 12%; LH/FSH, 9%; LH- or FSH-only, 2%; total 
lactotropes, somatotropes, and mammosomatotropes, 50%; GH-only, 22%; PRL-only, 
23%; and GH/PRL, 6%. Estradiol treatment increased (P < .05) pituitary concentrations 
of LH, FSH, and PRL. Estradiol also reduced (P < .05) the number of cells stained for
xii
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LH/FSH and increased (P < .05) the number of lactotropes and mammosomatotropes. 
DHT reduced (P < .05) pituitary concentrations o f LH and FSH but did not significantly 
affect tissue concentrations of PRL or GH. DHT reduced (P < .05) the number of cells 
that stained for LH/FSH and it increased (P<.05) the number of FSH-only cells. It is 
concluded that equine pituitary gonadotropes are subdivided into cells which contain one 
or both gonadotropins; and PRL and GH also, can be found in separate cells or in same 
secretory granules within one cell. Furthermore, OVX and steroid treatment 
preferentially regulate hormone secretion from gonadotropes that produce both LH and 
FSH as well as the number of ir-lactotropes and mammosomatotropes.
Xlll
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CHAPTER I 
INTRODUCTION
Literature in the area of equine endocrinology and reproductive physiology is 
scarce and lags behind that of other domesticated species. However, in reality, horses 
could be ideal models to study various aspects of reproductive physiology and 
endocrinology. One of the unique features of the equine reproductive cycle is the 
prolonged estrus period (about 7 days) which would provide a window to study the 
ovarian and pituitary interactions during this phase of the estrous cycle. By treating 
animals with exogenous steroids and/or hypothalamic factors, one could also shed light 
on the nature of pituitary cellular responses to various humoral factors.
Another rather unique feature of the equine reproductive cycle is reflected in 
humoral changes that occur during different seasons (i.e. ovulatory versus anovulatory 
season) and the possible regulatory role of hormones, such as prolactin (PRL) in seasonal 
reproductive patterns. Growth hormone (GH), which may not be considered as a 
reproductive hormone, has recently been getting some attention and its possible 
interaction with prolactin during different physiological states is being studied. Basic 
morphological information on the gland that produces these hormones (i.e., the pituitary) 
and data on the effect of ovarian steroids on morphology and immunoreactive (ir)- 
staining of pituitary cells do not exist for the equine species. Therefore, the research 
projects in this dissertation were performed to provide the basic information on subsets of 
pituitary cells in intact and ovariectomized (OVX) pony mares and to study the effect of 
steroid treatments on morphology and ir-staining of hormones in pituitary cell 
populations.
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CHAPTER n  
LITERATURE REVIEW 
The Hypophysis (Pituitary Gland)
Figure 2.1 illustrates the subdivisions of the equine pituitary, which can be 
divided into a glandular (adenohypophysis) and a neural portion (neurohypophysis). The 
glandular portion is subdivided into the pars distalis, pars intermedia, and pars tuberalis. 
The neural portion can be subdivided into the infundibulum/median eminence and pars 
nervosa [2.1, 2.2].
Adenohypophysis (Anterior Pituitary)
The adenohypophysis (AP) is composed of a solid mass of tightly packed 
epithelial cells which have been divided into three groups based on their histological 
staining characteristics; chromophobes, acidophils, and basophils. Prolactin and GH are 
secreted by the acidophils; luteinizing hormone (LH), follicle-stimulating hormone (FSH), 
and thyroid-stimulating hormone (TSH) are secreted by basophils; and chromophobes do 
not produce or contain ir-hormones. Corticotropes, which secrete adrenocorticotropic 
hormone and melanocyte stimulating hormone, are also considered to be basophilic. The 
carbohydrate moieties on hormones produced by basophils are responsible for the 
histological staining characteristics of this cell type [2.1, 2.2].
Pars Distalis. Once developed, the pars distalis (PD) is composed of secretory 
and non-secretory epithelial cells, a connective tissue stroma, and many fenestrated 
capillaries. The PD accounts for most of the mass of the AP. Despite its close proximity 
to the brain, the PD contains only a few nerve terminals related to the limited number of






Figure 2.1. Schematic illustration of the equine pituitary. PD = Pars distalis, PI = Pars 
intermedia, PT = Pars tuberalis, NL = Neural lobe, and ME = Median eminence. 
Adapted from Melrose PA, unpublished, with permission.
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axons that enter the AP along the blood vessels [2.1]. The non-secretory cells in PD are 
called foUiculostellate cells. These stellate-shaped cells have long cytoplasmic processes 
that extend between neighboring granulated cells. Studies have shown that gap junctions 
are present only between foUiculostellate ceUs and granulated ceUs [2.1, 2.2]. Soji and 
Herbert [2.3], on the basis of freeze fracture electron microscopic studies, proposed that 
the foUiculostellate cells form a network that serves as a syncytium to permit rapid 
communication between cells that lack innervation.
There is no blood-brain barrier in the PD [2.2, 2.4]. The presence of fenestrated 
capillaries and the organization of secretory epithelial cells in the PD allows hypothalamic 
hormones to freely diffuse into the nearby capillaries for subsequent delivery to cords and 
clusters of pituitary cells immediately adjacent to AP capillaries. Thus, hormones 
released from neurons in the basal forebrain are rapidly delivered to AP cells in order to 
allow for almost simultaneous release of various hypothalamic and pituitary hormones. 
Anatomy of the PD also facilitates exposure of pituitary cells to hormones from 
peripheral endocrine glands. Furthermore, organization of the PD allows hormone (s) 
produced by various PD cells to have paracrine effects on pituitary hormone secretion 
[2.4]. Due to the presence of gap junctions between adjacent AP ceUs, ions and 
hormones may diffuse between different hormone secreting cell types [2.3, 2.5, 2.6, 2.7]. 
Therefore, the anatomy of PD facilitates hormonal, paracrine, and ionic communication.
Pars Intermedia. The pars intermedia (PI) is prominent in horses. The PI in the 
human pituitary is a poorly developed, rudimentary structure with no apparent endocrine 
significance, except in pregnant women and the human fetus. The PI is less vascularized
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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than the PD [2.8]. In the rat's PI, capillaries join with the capillaries of the PD [2.8]. 
These vascular arrangements form the short portal plexus which functions to deliver 
products of the PI to the neural lobe and PD or to deliver secretions from the neural lobe 
and PD to the PI [2.9].
Axons terminate in the PI and make synaptoid contact with epithelial cells, and 
hence PI cells can be regulated by direct neural contact. Therefore, epithelial cells of the 
PI can be regulated by long portal routes from the median eminence via the PD, "short" 
portal routes from the neural lobe, and synaptic contact [2.2].
Pars Tuberalis. This segment of the AP is comprised of glandular epithelial cells 
arranged in cords and containing dense cytoplasmic granules. Pars tuberalis (PT)-specific 
cells and follicular cells are found in this subdivision of the AP [2.10]. Pars tuberalis- 
specific cells are spheroid in shape and are characterized by the presence of only a few 
secretory granules located at the vascular pole of the cell. These granules are generally 
smaller than those found in PD cells. Varying numbers of glycogen granules are present 
in the cytoplasm and these are a distinguishing characteristic of PT-specific cells. 
Follicular cells, in the human fetal pituitary, have irregular heterochromatic nuclei, no 
secretory granules, and long processes that extended between secretory cells. At the 
surface, the follicular cells are lined with microvilli and cilia. Occasionally, an axon 
terminal is found adjacent to a glandular epithelial cell [2.10]. Gonadotropes have been 
localized within the PT of the rat [2.11] and in the PT of the monkey (Macacca mulatto) 
[2.12, 2.13]. Girod et al. [2.13] reported localization of P-LH in basophilic cells of the 
PT \nMacacca irus. Following hypophysectomy of rats, there was an increase in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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number and size of ir-gonadotropes in the PT and an increase in gonadotropin hormone 
production [2.14].
Function of the PT is unknown. It has been reported that the PT is rich in 
melatonin receptors, and there is suggestive evidence that these receptors are found in 
PT-specific cells [2.15]. In some species, the morphology of PT-specific cells varied with 
photoperiod and not with functional changes in endocrine organs that are targets of the 
pituitary [for review refer to 2.16].
Neurohypophysis (Neural Lobe/Pars Nervosa)
The neural lobe is primarily composed of glial cells, pituicytes, axons, nerve 
terminals, and capillaries [2.2]. Ultrastructural studies in rats [2.17], mice [2.18], rabbits 
[2.19], and humans [2.20, 2.21] have revealed that there is a striking similarity in 
anatomy and composition of the neural lobe in various mammals [2.22].
The funnel shaped area of the neurohypophyseal portion of the hypophysis is 
located at the base of the third ventricle and is referred to as the infundibulum. The 
principal elements of the infundibulum include axons of magnocellular hypothalamic 
neurons, axons and terminals of parvicellular hypothalamic neurons which are associated 
with median eminence vasculature, and glial cells [2.2]. The external portion of the 
infundibulum principally contains axon terminals and axons of parvicellular neurons, 
median eminence vasculature, and glial cells. Axons passing through the infundibulum 
originate from magnocellular perikarya localized in the supraoptic and paraventricular 
nuclei of the hypothalamus. These axons form the “supraopticohypophyseal tract”.
Distal segments of these axons are characterized by the presence of large acidophilic non-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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terminal dilations, which are filled with neurosecretory substance. These swellings are 
referred to as Herring bodies [2.2]. Penetration of primary portal plexus capillaries into 
the central region of the infiindibulum creates the neurovascular structure that is closely 
related to axon terminals of parvicellular hypothalamic neurons. This structure is 
commonly referred to as the median eminence. Most of the parvicellular axon terminals 
that are found in this area contain and release various hormones or amines that control 
hormone secretion fi-om the PD [2.1, 2.4].
The pars nervosa accounts for the largest mass of the equine neurohypophysis 
(Figure 2.1). It principally contains pituicytes. Herring bodies, axon terminals of 
magnocellular neurons, and a well developed capillary system. A detailed histological 
description of the neurohypophysis is not included in this review since structure of this 
subdivision was not characterized as part o f this project.
Blood Supply to the AP
The internal carotid arteries give rise to rostroventral infundibular (hypophyseal) 
arteries, which supply the ventral region of the primary capillary plexus in the median 
eminence. The caudal communicating branches of the circle of Willis branch into the 
rostrodorsal infundibular arteries which supply the dorsal region of the pituitary portal 
plexus. Median eminence vasculature converges to form the long portal vessels in the 
external layer of the infundibulum. These vessels break up into a second capillary bed in 
thePD [2.23-2.26].
The primary function of median eminence capillaries and the pituitary portal 
vessels is to efficiently carry hypothalamic regulatory compounds to the AP. The second
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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capillary bed in the AP also facilitates diSlision of pituitary hormones into the systemic 
circulation for efficient delivery to peripheral target tissues [2.1, 2.4].
Control of LH and FSH Secretion
Gonadotropin-Releasing Hormone (GnRHl Secretion and Effectiveness.
Regulation of pituitary LH and FSH synthesis and secretion is primarily controlled by 
GnRH. Characteristics of gonadotropin secretion are dependent on the pattern of GnRH 
secretion. Hourly high frequency administration of GnRH to pituitary stalk-sectioned 
OVX sheep and monkeys preferentially causes the release of LH, whereas, slow 
frequency GnRH pulses (one injection every 3 hours) resulted in an increase in circulating 
FSH [2.27, 2.28]. Similar results have been reported for mares during the anestrus 
season. Specifically, infusion of GnRH every 45 minutes resulted in preferential release 
of LH whereas GnRH infusion every 6 hours resulted in an increase in circulating FSH 
[2.29]. Chronic administration of GnRH agonist resulted in down-regulation of LH and 
FSH secretion which subsequently suppressed an array of reproductive functions [2.30, 
2.31]. Chronic infusion (28 days) of GnRH agonist to mares resulted in suppression of 
LH output by the pituitary [2.32]. Montovan et al. [2.33] reported that mares required 
up to 30 days of GnRH treatment for any significant suppression to occur; however, 
chronic treatment with GnRH did not alter the sexual behavior of stallions.
Administration of a single large dose of a GnRH agonist to mares prolonged the estrous 
cycle [2.34]. Thus, horses require prolonged treatment with GnRH to suppress ovarian 
and sexual functions and equine pituitary GnRH receptors are apparently relatively 
insensitive to long-term treatment with GnRH.
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During estrus, GnRH pulse rate increased to a maximum frequency of two pulses 
per hour as measured in pituitary venous blood of horse mares [2.35,2.36]. At the time 
of maximal GnRH pulse frequency, LH rises and FSH is suppressed. Conversely, in the 
mid-luteal phase, gonadotropin pulses occur approximately twice daily. Preliminary 
measurements of GnRH in pituitary venous blood show that GnRH pulse rate is lower 
during the luteal phase than during the periovulatory surge; however, the decline in 
GnRH pulse frequency, and a large percentage of GnRH pulses are not effective in 
stimulating gonadotropin release [2.37]. Whether the apparent uncoupling of GnRH and 
gonadotropin secretion is a real phenomenon is not clear. It is possible that methods 
which depend on measurement of GnRH in blood which has already passed through the 
pituitary gland, and is therefore depleted of decapeptide due to binding of hormone to 
target cells and enzymatic breakdown, may not detect some secretory pulses of GnRH 
[2.37].
In horses, secretion of both LH and FSH is normally stimulated by GnRH [2.35, 
2.37-2.39], However, active immunization of intact mares with GnRH-conj ugates 
resulted in a greater reduction in circulating concentrations of LH than FSH [2.40]. The 
authors concluded that LH and to some degree FSH secretion, and probably LH 
production, in the mare are dependent upon the bioavailability and quantity of GnRH. 
However, the lack of effect of GnRH-immunization on FSH response to a GnRH analog 
suggests that FSH stores in the pituitary may be relatively independent of GnRH 
bioavailability.
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Estradiol Effects on Gonadotropins. Administration of estradiol to women or 
female animals is followed by an initial suppression of plasma LH and FSH, but both 
gonadotropins, particularly LH, are subsequently increased [2.41]. These observations 
have been confirmed in numerous studies and estradiol consistently exerts a biphasic 
effect on gonadotropin secretion. The time course of the biphasic action depends upon 
the species and upon the dose of estradiol used [ for reviews refer to 2.42, 2.43].
The negative eSect of estradiol on pulsatile LH secretion was first observed in 
ovariectomized monkeys by Yamajia et al. [2.44] in 1972. Infusion of a dose of 
estradiol, which restored the level of circulating steroid found in the early to mid- 
follicular phase of the menstrual cycle, led to a profound suppression of the hourly 
discharge of LH pulses [2.45 2.46]. This negative effect of estradiol plays a major role in 
the regulation of tonic LH secretion during the course of the menstrual cycle in the rhesus 
monkey [2.47]. Subsequent studies led to the conclusion that the negative feedback 
effects of estradiol in the monkey are produced, in large measure, by action on the 
pituitary which suppresses the response to GnRH [2.42]. The negative effects of 
estradiol have been studied in other species (for reviews refer to 2.43, 2.48]. Available 
evidence from these animals indicates that estradiol acts principally on the central nervous 
system (CNS) in pigs, and exerts significant actions on both the pituitary and the CNS in 
sheep and cattle.
Estradiol can also exert a positive effect on the pituitary release of LH. Following 
the administration of estradiol, the pattern of LH secretion varies with time and the extent 
to which circulating estradiol is elevated. In most mammalian species, if the estradiol
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level is high enough (i.e., upper physiological range), the initial negative feedback 
response is interrupted by an LH surge comparable to the massive discharge that induces 
ovulation during the estrous cycle [for reviews refer to 2.48- 2.52]. The latency to onset 
of this response, referred to as the positive feedback response, depends upon the blood 
level of estradiol achieved. Within limits, the higher the estradiol level, the shorter the 
latency to the LH surge [2.48, 2.51].
In the mare, endogenous concentrations of estradiol begin to increase 6 to 8 days 
before ovulation (approximately at the start of the estrus) and plasma estradiol 
concentrations peak about 2 days before ovulation [2.53, 2.54]. Low luteal-phase values 
of estrogens are regained within a day or two after ovulation [2.53, 2.54]. In the mare, 
estradiol administration does not lead to an ovulatory LH surge nor does it cause marked 
LH suppression. However, long-term treatment of OVX mares with estradiol raises LH 
levels for the duration of treatment in both the breeding and nonbreeding seasons [2.55, 
2.56].
There is some evidence that estradiol may interact with GnRH to influence the 
form of circulating LH in mare. Treatment of anestrus mares with estradiol followed by 
hourly pulses of GnRH results in a sustained increase in the relative in vitro biological 
activity of plasma LH [2.57]. Treatment with either hormone alone does not alter LH 
bioactivity in seasonally anestrus mares [2.57]. In subsequent studies, the combination of 
estradiol and GnRH treatments was designed to mimic hormonal events during the 
periovulatory period when the relative bioactivity of plasma LH normally increases
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[2.58], Results form this work suggest that the interaction between estradiol and GnRH 
may produce this normal increase in bioactivity of LH.
Effect of estradiol on FSH has not been investigated as thoroughly as effects on 
LH. However, it is generally agreed that administration of estradiol suppresses FSH in 
women, monkeys, and sheep [for review refer to 2.59]. Experiments using pituitary cells 
in culture have shown that estradiol inhibition of FSH responses to GnRH involves 
inhibition of FSH synthesis. Synthesis of FSH is decreased after 6 to 8 hours of 
gonadotrope exposure to estradiol [2.54]. Furthermore, immunization of sheep against 
estradiol raises FSH and increases follicular development [2.59]. In OVX mares, 
contradictory results have been obtained with estradiol treatment. Some workers have 
found no effect of estradiol on FSH either in the breeding season or nonbreeding season 
[2.55], whereas others have reported that FSH was suppressed by estradiol treatment 
[2.56, 2.60].
Androgen Effects on Gonadotropins. It is well established that androgens 
regulate the secretion and synthesis of gonadotropins differentially. Testosterone 
treatment of adult castrated rats results in an increase in pituitary content of FSH, but 
a decline in LH content [2.61]. More recent studies have shown that differential 
regulation of in vivo gonadotropin synthesis occurs at the pre-translational level in 
both male and female rats [2.62-2.65]. In vivo studies have also shown that androgens 
negatively regulate only a  and LHP subunit mRNA levels, having little or no effect on 
FSnp subunit levels [2.62-2.64]. Gharib et al. [2.65] showed that in vitro treatment of 
rat pituitary cells with androgens positively regulated FSHP subunit mRNA levels but
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has no effect on a or LHP subunit mRNA levels. However, organ cultures of adult 
female pituitaries, when treated with DHT for 5 days, have increased stores of FSH 
but markedly decreased stores of LH [2.66, 2.67]. The effects of DHT on LH and 
FSH also reportedly include a reduction in LH and FSH secretion, increased pituitary 
content of FSH, and reduced pituitary content of LH [2.56, 2.68-2.71].
Thompson et al. [2.72] reported that treatment o f mares with testosterone 
propionate (TP) during late estrus or early diestrous reduced circulating FSH 
concentrations. However, GnRH treatment of these mares resulted in increased plasma 
FSH levels. Administration of TP during estrus did not have any effect on its duration; 
however, a postovulatory surge in FSH was measured in these mares [2.72]. Thus, TP 
treatment of late estrus and early diestrus mares causes an initial suppression and a later 
rebound in FSH release. Based on these findings, Thompson et al. [2.73] hypothesized 
that synchronization of mares with altrenogest (a progestogen) could be followed by 
testosterone to induce a midcycle-like surge of FSH. Related experimental results 
confirmed that the combined treatment initially decreased plasma FSH levels, but plasma 
FSH subsequently increased over the pretreatment baseline. Administration of androgens 
to mares also increased pituitary FSH. This pool of FSH was readily released by GnRH 
treatment [2.56, 2.73]. Thus, Thompson and coworkers concluded that androgens may 
play a role in accumulation of pituitary FSH during the estrus period so that a releasable 
pool of this gonadotropin is available for later release during diestrus.
Other studies by Thompson’s group [2.60, 2.71, 2.74-2.76] addressed the 
question of whether testosterone or aromatized testosterone metabolites are responsible
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for TP effects on FSH. In these experiments, ponies were actively immunized against 
estradiol and later treated with TP. This treatment protocol resulted in about a 50% 
reduction in the stimulatory effect of TP treatment on pituitary FSH concentrations 
[2.74]. Thus, androgens and estrogens act together to produce effects of TP on pituitary 
FSH. Collectively, these data suggested that androgens and androgen metabolites 
produced by follicles during early diestrus exert a positive effect on FSH. This effect 
could also be responsible for the diestrus surge of FSH.
Control of GH Secretion
Little is known about GH secretion in horse. However, GH from the equine 
anterior pituitary gland has been characterized [2.77-2.81]. The amino acid sequence for 
equine GH [2.82] and nucleotide sequence cDNA for equine GH have been determined 
[2.83].
Fluctuations in the circulating concentrations of GH in different farm and 
laboratory animals, primates, and humans have been characterized [2.84-2.89]. Growth 
hormone secretion is pulsatile or episodic with high amplitude GH pulses superimposed 
over a low constant baseline in monkeys [2.87] and pigs [2.88] or over a variable 
irregular baseline in cattle [2.84] and sheep [2.89]. Elevated plasma GH concentrations 
are not necessarily correlated with any immediate physiological changes [for review refer 
to 2.86]. However, several physical and metabolic factors have been shown to be related 
to increased plasma GH concentrations. Factors effecting GH secretion include slow- 
wave sleep and posture in sheep [2.89]; age (youth) in sheep, monkeys, and pigs [2.85,
2.87, 2.88]; gender in pigs [2.90]; fasting, exercise, trauma, and deep sleep in humans
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[for review refer to 2.86]; and poor nutritional status in sheep and cattle [2.91-2.93], In 
addition, GH-releasing hormone (GHRH) has been characterized for several species 
[2.94-2.96]. This hypothalamic hormone results in rapid secretion of GH whereas 
somatostatin inhibits GHRH-induced GH release and GH synthesis [2.94-2.96].
Stewart [2.97] reported GH release in the horse is pulsatile and similar to 
secretory patterns reported in other species. Thompson et al. [2.98] reported that 
although GH concentrations varied in a pulsatile manner in all horses studied, there was 
no effect of sex or season on plasma GH concentrations and no indication of a diurnal 
pattern of GH secretion. Treatment of horses with GHRH increased plasma GH 
concentrations. Plasma GH was also increased when stallions were exposed to estrous 
mares or following an acute exercise bout. Restraint and/or epinephrine administration 
also increased plasma GH concentrations. Thompson and coworkers concluded that the 
secretory patterns of GH in mares and stallions are episodic and/or pulsatile in nature;
GH secretion is part of the overall hormonal response to stimulation of the sympathetic 
nervous system; and there is no co-secretion of GH and prolactin following thyrotropin- 
releasing hormone (TRH) or sulpiride treatments. In a follow up study, Thompson et al. 
[2.99] reported GH pulses were more frequent and had a greater amplitude in stallions 
and geldings as compared to GH secretory patterns in mares. Growth hormone secretion 
following restraint via a twitch or epinephrine administration was also greater in stallions 
than in mares or in geldings. Finally, exercise-induced plasma concentrations of GH were 
greater in geldings than in mares and stallions.
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Control of PRL Secretion
Chen and Meites [2.100] and Cheng and Johnson [2.101] reported the stimulatory 
effects of gonadal steroids on PRL in OVX rats more than twenty years ago. Moreover, 
there are several reports concerning PRL secretion and storage in horses [2.56, 2.102- 
2.108]. Johnson [2.105] found no change in PRL secretion throughout the estrous 
cycle of mares. Worthy et al. [2.104] reported brief increases in PRL secretion at the 
end of diestrous in three pony mares; however, the exact pattern of PRL secretion 
during the estrous cycle was not clear. Thompson et al. [2.56] reported that treatment 
of OVX pony mares with estradiol increased pituitary content of PRL, but this 
treatment did not increase serum PRL concentrations. These authors also reported that 
treatment of OVX pony mares with DHT or testosterone increased the PRL response 
to exogenous TRH, even though neither androgen had any effect on daily secretion or 
storage of PRL [2.56].
Experiments Testing for the Effects of Androgens and Estrogens on LH, FSH, 
PRL, and GH
Numerous publications describe the effects of reproductive steroids on 
production, secretion, and storage of LH and FSH in the equine species [2.55, 2.60, 
2.68-2.70, 2.72-2.76, 2.109-2.115]. It is also well estabUshed that LH and FSH 
content of the pituitary is profoundly influenced by reproductive steroids [2.56, 2.75, 
2.115]. Thompson and coworkers [2.56] previously evaluated the relationship between 
hormone secretion and storage and pituitary response to secretagogue after steroid 
treatment of OVX pony mares. These authors concluded that estradiol had a positive
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effect on LH secretion and storage whereas it had a negative effect on FSH secretion. 
However, estradiol increased the pituitary concentration of FSH. Androgen treatment 
of the ponies lowered LH secretion and storage and it reduced FSH secretion while 
increasing storage of FSH.
Hassan et al. [2.116] studied the effect of sex steroids on basal GH and 
GHRH-stimulated release of GH in bovine pituitary cell cultures. They found that at 
the doses tested, sex steroids did not affect basal release of GH, but androgens 
increased GHRH-induced GH release. Studies in rats [2.117, 2.118] showed that 
pretreatment of castrated males with testosterone significantly enhanced the pituitary 
GH response to GHRH, whereas pretreatment of OVX female rats with estradiol did 
not alter the response. Administration of testosterone to juvenile male rhesus monkeys 
[2.119] increased blood PRL, pituitary PRL content, and the number of lactotropes. 
However, in baboons [2.120], administration of a physiological dose of estrogen did 
not increase GH concentrations, whereas a pharmacological dose of estrogen given to 
intact female baboons increased serum GH. Estradiol treatment of pituitary cultures 
has yielded both positive and negative results on GH synthesis [2.121-22.4].
Treatment of OVX pony mares with androgens and a subsequent challenge by 
TRH increased plasma PRL concentrations [2.56]. Apparently androgens enhanced 
the sensitivity of the pituitary PRL response to TRH. Nogami [2.125] reported that 
testosterone administration decreased PRL secretion in male rats whereas androgen 
treatment of juvenile monkeys increased pituitary PRL content and the number of PRL 
secreting cells [2.119].
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Immunocytochemical Staining of Gonadotropes
Prior to the development of immunocytochemical methods, cytologists 
differentiated two morphological subsets of cells which were believed to synthesize 
and store gonadotropins [2.126, 2.127]. The classical Kurosumi-Oota [2.127] FSH 
cell was large, ovoid, and contained a population of large (^400 nm) and small («200 
nm) diameter granules. The Kurosumi-Oota LH cell was angular and contained 
scattered granules 2(X) nm in diameter.
The first electron microscopic-immunocytochemical studies of Nakane [2.128] 
demonstrated that LH was in the “classical FSH cell" previously described by 
Kurosumi and Cota [2.127]. Follicle-stimulating hormone was also in the Kurosumi- 
Oota FSH cell and in a cell which was angular and contained small, peripherally 
arranged granules. Tougard et al. [2.129] and Tixier-Vidal et al. [2.130] reported the 
presence of LH and its subunits in both classical FSH and LH cells in male rats. Thus, 
it was concluded that both gonadotropins can exist in one cell and that one could not 
distinguish FSH and LH cells on the basis of morphology.
Several investigators have since documented the secretion or localization of 
more than one hormone by or in individual pituitary cells in different species including 
dogs [2.131], mice [2.132], rats [2.133, 2.134], pigs [2.135, 2.136], humans [2.137], 
and sheep [2.138]. However, Basting et al. [2.139] reported that dual-localization of 
both ir-gonadotropins in one cell type does not hold true for the bovine species.
The introduction of post-embedding immunocytochemistry methods based on 
specific primary antibodies and immunogold secondary conjugates, especially protein 
A-gold and gold conjugates to secondary antibodies [2.140-2.142], has enabled
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researchers to study the ultrastructural localization of tissue antigens. These techniques 
facilitate studies on the mechanism of production, transport, and processing of ir- 
hormones and they help to conclusively demonstrate co-existence of two or more 
distinct hormones in the same secretory granules [2.143]. This technique also allows 
one to perform double labeling for ultrastructural immunocytochemical staining of 
conventionally processed, resin-embedded tissues [2.143].
Gonadotropes comprised 10 to 15% of sheep pituitary cells and, in this cell 
group, 57% of the cells stained for LH and FSH and about 34% and 8% stained only 
for LH and FSH, respectively. However, in OVX ewes, 75 % of the gonadotropes 
contained both ir-hormones, 22% of the cells stained only for LH, and 3% stained 
only for FSH [2.119]. In OVX rats, the gonadotrope cell population included a large 
(75-85%) cell group that stained for LH and FSH and about 20% of the gonadotropes 
stained for a single gonadotropin [2.138]. In pigs, 21 to 25% and 24 to 37% of the 
gonadotropes contained both ir-hormones in intact and OVX animals, respectively 
[2.136].
Immunocytochemical Staining of Lactotropes and Somatotropes
Immunoperoxidase and immunogold labeling techniques have been used in 
conjunction with specific primary antibodies to identify cells that produce GH and PRL in 
normal tissue and in pituitary tumors in monkeys [2.144], humans [2.145-2.148], rats 
[2.149-2.152], hamsters [2.153, 2.154], pigs [2.155], goats [2.156], cows [2.157-2.160], 
sheep [2.161-2.163], and musk shrews [2.164-2.166]. Tashjian and coworkers [2.167] 
suggested that the production of both GH and PRL from one cell type occurs in rodent 
pituitary tumors. Further studies by Zimmerman et al. [2.168] showed that certain areas
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of normal human pituitaries contain numerous cells that stain for both GH and PRL and 
these cells represented more than 50% of the total number of cells in the AP. They 
concluded that a significant population o f cells normally contain both of these hormones 
in human pituitaries. More recent investigations, utilizing immunocytochemical 
techniques and electron microscopic study, have supported the conclusion that PRL and 
GH normally co-exist in cells of adult and fetal human pituitaries [2.169-2.171], human 
pituitary adenomas [2.147, 2.168, 2.172-2.175], and normal rat [2.176, 2.177] and cow 
[2.178, 2.179] pituitaries. Moreover, pituitary cells that secrete both GH and PRL 
simultaneously (mammosomatotropes) have been reported in studies where hemolytic 
plaque assay technique was utilized [2.178-2.180].
Several reports have classified lactotropes into two or three types based on 
morphology of the secretory granules and size of the cells [2.159, 2.160]. These subsets 
of lactotropes have not always been differentiated in immunocytochemical experiments 
on pituitary tissues obtained from various domestic species. An electron microscopy 
study done by Mikami [2.157] indicated that large lactotropes in the bovine pituitary 
gland were round or oval in shape; these cells contained large, dense granules, which 
were spherical or polymorphic in shape. Ultrastructural studies by Heath [2.181] 
indicated that secretory granules of lactotropes in bovine pituitary are the largest in 
diameter compared to granules in other cells. Results from a similar 
immunohistochemical study of Dacheux and Dubois [2.158] showed that PRL secreting 
cells in bovine pituitaries contain large secretory granules. However, these authors 
emphasized that the granules in lactotropes were smaller in diameter than the secretory 
granules in somatotropes. In goats [2.156], it has been reported that lactotropes contain
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the largest secretory granules as compared to size of secretory granules in other hormone 
secretory cell groups in the pituitary gland.
Storage and secretion of GH and PRL were typically considered to be a function 
of two distinct pituitary cell types [2.177]. However, there are reports that a third cell 
type contains and secretes both hormones. Mammosomatotropes have also been found in 
mice [2.182], rats [2.177, 2.178,2.183], musk shrews [2.183], and cows [2.159, 2.160, 
2.179]. In lactating rats, 26% of cells in the pituitary contained both GH and PRL 
[2.177], However, Thorpe et al. [2.162] reported that only 2 cells out of 1800 cells 
counted contained both GH and PRL in sheep pituitary. In a similar study, Thorpe and 
Wallis [2.163] cultured sheep pituitary cells and reported that 3% of the cells stained for 
both GH and PRL. However, by the end of the 96 hour of culture, <0.2% of the cells 
contained both ir-PRL and ir-GH. The decrease in the mammosomatotropic cell 
population was presumed to be due to cell culture, which typically depletes or reduces 
cellular hormone concentrations, and/or to the removal of hypothalamic factors that 
support normal functions of these cells.
There seems to be two distinct localization patterns for hormone storage in 
mammosomatotropes found in musk shrews and rats. In one, PRL and GH were 
packaged in separate granules within the same cell. These were found in pregnant 
animals. In the other type of storage pattern, both hormones are co-packaged in the 
same secretory granules [2.183]. Fumagalli and Zanini [2.159] reported the presence of 
multi-nucleated mammosomatotropes in bovine pituitary gland. These authors reported 
that GH and PRL are packaged in three different ways; evenly intermixed together in the
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same granule, localized in different granules within the same cell, or localized in the same 
granules but with the individual ir-hormone segregated in different portions of the 
granule.
Goluboff and Ezrin [2.184] suggested that ovarian steroids could influence the 
interconversion of somatotrope and lactotrope cells. Placental steroids (presumably 
estrogen) were also suggested to be involved in reciprocal shifts between these ir-cell 
types since exogenous administration of estradiol caused radiolabeled somatotropes to 
take on the morphological characteristics of PRL-producing cells in the rat [2.185]. 
Boockfor et al. [2.186] utilized a reverse hemolytic plaque assay with pituitary cell 
cultures from male rats to provide the first direct evidence that estrogens caused a 
marked increase in the proportion of ir-mammosomatotropes and a concomitant decrease 
in the relative proportion of cells that stain only for GH. These authors suggested that 
estradiol may convert cells that release only GH to those that release both GH and PRL. 
Other studies have shown considerable fluctuation in the number of cells which produce 
GH, PRL, or both hormones throughout the annual reproductive cycle of bats and musk 
shrews and during the transition from early pregnancy through the end of lactation in rats 
[2.183-2.188].
Estradiol effects on somatotropes is a controversial issue and seems to be 
species specific. In estradiol-treated rat pituitary cultures, Simard [2.122] reported a 2- 
to 3-fold increase in GH release as well as cellular content. Bethea and Freesh [2.123] 
and Copeland [2.120] reported that in primates, physiological doses of estradiol do not 
stimulate GH release. Kineman et al. [2.124], by means of reverse hemolytic plaque
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assay on cow pituitary cell cultures, showed that the percentage of all pituitary cells that 
released PRL was greater in the early luteal phase (day 1-10) than during other phases of 
the estrous cycle. However, GH-secreting cells remained unchanged throughout the 
entire estrous cycle. Furthermore, the increase in total PRL secreting cells was attributed 
to an increase in the number of cells that secreted both GH and PRL, while the number of 
GH-only cells decreased without a change in PRL-only cell numbers. These authors 
concluded that there is a reciprocal interconversion of cells that release only GH and 
mammosomatotrope cells during the estrous cycle. They also suggested that the 
relationship between ratios of somatotropes, lactotropes, and mammosomatotropes and 
stage of reproductive cycle indicates that ovarian steroids may regulate this phenomenon. 
A similar study compared localization of ir-hormones in pituitaries from bulls and steers 
to determine the role of gonadal steroids on the ratios o f GH-only and dual-hormone 
secreting cells [2.189]. In gonadally intact bulls, approximately 9% of all pituitary cells 
stained for GH and PRL, whereas 21% stained only for GH, and 45% stained only for 
PRL. However, a different scenario existed in steers where mammosomatotropes 
comprised 22% of the pituitary cell population and cells that stained only for GH or only 
for PRL accounted for 8% and 46% of the total number of pituitary cells, respectively. 
These results, along with the results from the cow study, indicated that gonadal steroids 
may have a profound effect on the secretory characteristics and immunocytochemical 
staining properties of bovine pituitary cells.
Stratmarm et al. [2.185] reported that following 21-day treatment of rats with 
estradiol there was a transformation of somatotropes to lactotropes. Later, Nogami
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[2.125] also showed that stimulation of newborn and adult rats with estradiol resulted in 
an increase in the number of ir-lactotropes. Finally, Frawley et al. [2.190] reported the 
presence of a distinct cell population in the pituitary that is capable of producing and 
secreting both GH and PRL concomitantly. Later on, studies from the same laboratory 
showed that the fluctuation in numbers of lactotropes and somatotropes is influenced by 
gonadal steroids [2.124, 2.190] and that there is a bi-directional interconversion of these 
two cell types which depends upon hormonal cues [2.188]. This fluctuation in 
proportions of pituitary cells has been proposed to be due to transdifferentiation (lose or 
gain the ability to secrete GH or PRL) [2.191, 2.192] of lactotropes and somatotropes. 
Although there is no major change in total cell number of PRL and GH cells due to 
different hormonal milieu, the possibility of cell division among the cells had not been 
ruled out. This possibility was examined by Kineman et al. [2.192] where bovine 
pituitary cell cultures were subjected to several stimuli followed by reverse hemolytic 
plaque assay. The results indicated that the acidophilic subpopulations are capable of 
transdifferentiation and no significant cell division was involved. However, the authors 
reported that estradiol was incapable of increasing PRL in their culture system.
There is no information with regard to ultrastructural morphology and relative 
abundance of any of the ir-hormone cell types in the equine pituitary. There is also lack 
of information on the behavior of the pituitary cells to different secretagogues and/or 
inhibitors. Therefore, the following experiments were preformed to characterize the 
ultrastructure and immunocytochemical staining properties o f hormone-producing cell 
groups in the pituitary of gonadally intact and OVX pony mares and to study the changes
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that steroids would induce in morphology and ratios of ir-LH-, FSH-, GH-, and PRL-
containing ceils. These studies are expected to determine whether various subgroups of
cells contain an ir-hormone. Secondly, results from these experiments may help to
differentiate individual pituitary cell populations that are sensitive to steroid feedback.
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CHAPTER m
IMMUNOCYTOCHEMICAL LOCALIZATION OF LH 
AND FSH IN THE EQUINE PITUITARY
Introduction
Prior to the development of immunocytochemical methods, cytologists 
differentiated two morphological subsets of cells that were believed to synthesize and 
store gonadotropins [3.1, 3.2]. The classical Kurosumi-Oota [3.2] FSH cell was large, 
ovoid, and contained a population of large (^400 nm) and small (-200 nm) granules.
The Kurosumi-Oota LH cell was angular and contained scattered granules 200 nm in 
diameter.
The first electron microscopic-immunocytochemical studies of Nakane [3.3] 
demonstrated that LH was in the “classical FSH cell” previously described by Kurosumi 
and Oota [3.2]. Follicle-stimulating hormone was also in the Kurosumi-Oota FSH cell 
and in a cell which was angular and contained small, peripherally arranged granules. 
Tougard et al. [3.4] and Tbder-Vidal et al. [3.5] reported the presence ofLH and its 
subunits in both classical FSH and LH cells in male rats. Thus, it was concluded that both 
gonadotropins can exist in one cell and that one could not distinguish FSH and LH cells 
on the basis of morphology. Since then, several investigators have documented the 
secretion of more than one hormone by individual pituitary cells in different species 
including dogs [3.6], mice [3.7], rats [3.8, 3. 9], pigs [3.10], humans [3.11], and sheep 
[3.12]. However, Basting et al. [3.13] reported that this duality in gonadotropin 
secretion from one cell type does not hold true in cattle.
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The introduction of immunogold techniques, especially protein A-goId and IgG- 
gold conjugates for post-embedding immunocytochemistry [3.14-3.16], has enabled 
researchers to study the ultrastructural localization of tissue antigens. This technique 
facilitates studies on the mechanism of production, transport, and processing of hormones 
and it helps to conclusively demonstrate coexistence of two or more distinct hormones in 
the same secretory granules [3.17]. This technique also allows one to perform double 
labeling for ultrastructural immunocytochemistry on conventionally processed, resin- 
embedded tissues [3.17].
We previously reported light microscopic results for immunocytochemically 
stained equine pituitary glands [3.18] that enabled us to differentiate the cell types and 
determine the distribution of different pituitary cells. This technique, however, only 
provided a coarse localization of hormones and a general distribution of the different cell 
types. A more discrete and precise labeling method was necessary in order to delineate 
more clearly the ultrastructural characteristics of the gonadotropes. Thus, the objectives 
of the present study were to: 1) identify and possibly differentiate gonadotropes more 
accurately; 2) determine if gonadotropins are contained in a single cell group or in 
distinct cell populations; and 3) estimate a relative abundance of each type of 
gonadotrope in the equine pituitary.
Materials and Methods
Pituitary Fixation and Embedding. Three adult pony mares in different 
reproductive states were used. The mares were kept on pasture and were fed grass hay 
as needed to maintain good body condition. The mares were euthanized and the
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pituitaries were removed within 7-12 min. The pituitaries were rinsed with saline and 
placed in freshly prepared 4% formaldehyde (Electron Microscopy Sciences, Fort 
Washington, PA) plus 0.1% glutaraldehyde (Polysciences, Warrington, PA) buffered with 
0.1 M sodium cacodylate (pH 7.3; Electron Microscopy Sciences). While in the fixative, 
the pituitaries were freed of the surrounding capsule and the anterior pituitary was 
removed from the neural lobe. The pituitary tissues were then cut into approximately 1 
mm’ pieces and fixation continued for two more hours. Following fixation, ten randomly 
selected pieces from each animal were removed and cut into smaller pieces; these were 
used for embedding. Tissues were washed several times in 0.1 M sodium cacodylate 
buffer to remove any residual aldehyde. Tissues were then dehydrated in 50% ethanol 
(EtOH) for 15 min, 70% EtOH for 20 min, and 90% EtOH for 30 min. Some of the 
tissue blocks were processed for routine Epon-Araldite electron microscopy as previously 
described by Poolsawat [3 19]. Tissues used for immunocytochemistry were infiltrated 
and then embedded with 60% LR Gold (LRG; Electron Microscopy Sciences) monomer : 
40% EtOH for 30 min; 70% LRG : 30% EtOH for 30 min; 100% LRG monomer for 2 h; 
100% LRG monomer plus 0.1% benzil (initiator) for 2 h; and finally overnight in 100% 
LRG monomer plus initiator. All procedures were performed at room temperature. The 
tissues were then embedded in small gelatin or large BEEM* capsules (Electron 
Microscopy Sciences). The LRG was polymerized under UV light at -15“C for 24 to 36 
h. Ultrathin, 80-90 nm light gold-colored sections were cut on a Sorvall MT2-B 
ultramicrotome and sections were mounted on 400 mesh gold grids.
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Presence of any follicles and/or corpora lutea on the ovaries was recorded and a 
blood sample from each animal was collected at the time of slaughter in a heparinized 
tube for progesterone analysis [3.20].
Primary Antibody Specificity and Cross-Reactivity. The polyclonal 
antibodies used were rabbit anti-equine (e) chorionic gonadotropin (eCG; here it will be 
referred to as anti-LH) [3.21] and rabbit anti-ovine (o) FSH (oFSH) [3.22]. The peptides 
used in pre-absorption tests for specificity were; bovine (b) LH (USDA-bLH-B-6), 
human (h) FSH (hFSH; FSH-I-SIAFD-1, Lot # AFP-5720D), porcine (p) prolactin 
(pPRL; USDA-pPRL-B-1), porcine growth hormone (pGH; USDA-pGH-B-1), bovine 
thyroid stimulating hormone (bTSH; USDA-bTSH-I-l), and hACTH (human ACTH-I- 
SIAFD-1, Lot # AFP-2938C). These peptides were obtained from the National 
Hormone and Pituitary Program (Rockville, MD). Primary antibodies used in this study 
were previously tested for specific immunocytochemical staining of pituitary hormones in 
free-floating sections processed for examination at the light microscopic level (3.18). In 
these experiments, primary antibodies were pre-absorbed with immunoglobulin fractions 
that cross-reacted with unrelated pituitary hormones, when the hormones were 
immobilized on a solid support and subsequently processed for immunocytochemical 
staining with avidin-biotin-peroxidase conjugates. In the present study, primary 
antibodies pre-absorbed with cross-reactive immunoglobulin fraction were used for post­
embedding immunocytochemical labeling and examination of tissues at the electron 
microscopic level. To this end, 10 pg of each of the aforementioned hormones, in 5 pi of 
0.05 M Tris buffer (pH 7.3), were spotted on nitrocellulose paper and allowed to air dry.
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They were then exposed to 4% formaldehyde vapor for 30 min and incubated with 100 pi 
of each primary antibody preparation for 50 hours at 4°C. Ultrathin sections were 
incubated with absorbed primary antibodies and processed for immunocytochemical 
staining as described below.
Immunogold labeling. Sections were first incubated for 10 min on a drop of 
Tris buffer containing 0.02 M glycine to quench any aldehyde left in the tissue. They 
were then incubated for 30 min on a drop of Tris buffer containing 1% BSA plus 10% 
normal goat serum (blocking solution) to reduce non-specific binding. The grids were 
then transferred to a 35 pi drop of the primary antibody (diluted 1:20 in the blocking 
solution) and they were incubated with diluted primary antibody for 2 h. Next, grids 
were blotted and rinsed four times on a drop of Tris buffer for 5 min each. Then the 
sections were blotted and transferred to a drop of the blocking solution for 5 min. They 
were then transferred to a 35 pi drop of a 20% solution (as recommended by the 
supplier) of goat anti-rabbit IgG gold conjugate (Electron Microscopy Sciences) and 
incubated for 50 min. The sizes of the gold particles used were 6 or 10 nm. The sections 
were then washed in Tris buffer with 2.5 M NaCl for 10 min and rinsed in distilled water. 
The final step involved incubating the sections on a drop of a 0.5% formaldehyde for 10 
min and rinsing with distilled water followed by complete drying.
Double labeling was done following a protocol described previously by Bendayan 
[3.17]. Briefly, following the above steps for one side of the grid, the grid was turned 
over and the same procedure was followed except that the primary antibody and the size 
of the gold particle were changed. The sections were counter-stained with uranyl acetate
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and Sato lead before examination with a Philips 410 Electron Microscope. In addition to 
the cross-reactivity procedures, other controls consisted of omitting the primary 
antibody step and testing for non-specific binding of pre-absorbed primary antibodies and 
gold-conjugates to the tissue. Primary antibodies were pre-absorbed with the peptides 
used in the preceding section.
Pituitary Cell Counts. To assess relative cell frequencies, ten grids per animal 
were viewed using an electron microscopy. One section per grid was used to count cells 
and to assess binding of the primary antibodies and gold-conjugates. Only cells sectioned 
through a nucleus were counted.
Results
Fixation of equine pituitary tissues in 4% formaldehyde with 0.1% glutaraldehyde 
followed by low temperature embedding in LRG resulted in an acceptable ultrastructural 
preservation of the organelles and cell membranes (Figure 3.1). For each primary 
antiserum, gold particles were concentrated over the secretory granules (Figure 3.1 
inset).
Specificity of the Antibodies. Only background binding of gold-conjugates was 
observed when normal goat serum or Tris buffer was used instead of the specific primary 
antibody (Figure 3.2). Staining was also equivalent to a nearly undetectable background 
when the primary antibodies were pre-absorbed with the specific antigen and sections 
were subsequently incubated with gold-conjugated IgG. For each primary antibody, the 
homologous antigen markedly reduced or completely abolished staining as illustrated in 
Figures 3.3 and 3.4. Staining with anti-LH and anti-FSH antibodies was not reduced or
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Figure 3.1. A cluster of gonadotropes in LH antibody-immunogold (10 nm)-stained 
equine pituitary tissue embedded in LRG. Nucleus (N). Bar =1.5 pm. Inset: An 
enlargement of an area of the cytoplasm shows gold particles on the secretory granules in 
a gonadotrope demonstrating distinct localization of LH. Bar = 3 pm.
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Figure 3.2. Staining and appearance of secretory granules in a gonadotrope processed 
without primary antibody: Staining is specific for anti-gonadotropin primary antibodies. 
Bar = .5 pm.
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Figure 3.3. Secretory granules in a gonadotrope embedded in LRG and stained with pre­
absorbed LH antibody. Binding of gold conjugate was almost abolished when LH 
antibody was pre-absorbed with the homologous antigen. Bar = .5 pm.
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Figure 3.4. Secretory granules in a gonadotrope embedded in LRG and stained with pre­
absorbed FSH antibody. Secretory granules in a gonadotrope embedded in LRG.
Staining was almost abolished when FSH antibody was pre-absorbed with the 
homologous antigen. Bar = .5 pm.
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abolished when primary antibodies were pre-absorbed with the heterologous 
gonadotropin (Figures 3.5, 3.6). Results for absorbtion with pGH, bTSH, pPRL, and 
hACTH are not shown; however, there was no inhibition of binding of primary antibodies 
or the gold particles to gonadotrope secretory granules when LH and FSH antibodies 
were absorbed with any of these antigens. Therefore, on pituitary sections, anti-LH 
antibody reacts only with LH containing cells and not others. Furthermore, the anti-FSH 
antibody reacts only with FSH containing cells and not others. Some gonadotropes 
contained vesicles that stained for both LH and FSH (Figures 3.7, 3.8).
Ultrastructural Morphology of the Gonadotropes. Gonadotropes single­
stained for LH or FSH were identical in morphology. They appeared as being round or 
ovoid in shape. The large nuclei tended to be polymorphic and were mostly eccentrically 
located in the cell (Figures 3.1, 3.9, 3.10). The cells contained scattered and dilated 
rough endoplasmic reticulum (RER). Gonadotropes were typically large cells but also 
showed considerable variability in size and ultrastructure. However, gonadotropes could 
be recognized ultrastructurally by their vesicular RER and the heterogeneous size of their 
granules (Figures 3.9-3.13). In some cells, the large and dilated cistern of RER had 
coalesced to form large vacuoles containing material o f low electron density (Figures
3.11, 3.12). The mitochondria were usually long and slender, although occasionally 
spherical, and they were generally concentrated in perinuclear areas.
The secretory granules in gonadotropes could be divided into two types: one was 
large and polymorphic and was generally located in the middle of the cells with 
occasional appearance close to the periphery; the other was smaller in size and was




Figure 3.5. Immunoreactive-LH cell processed with LH antibody which was pre­
absorbed with FSH. Absorbtion of LH antibody with FSH did not inhibit binding of the 
primary antibody and (10 nm) gold-conjugate to the LH containing secretory granules. 
Bar= .5 pm.




Figure 3.6. Immunoreactive-FSH cell processed with FSH antibody which was pre­
absorbed with LH. Absorbtion of FSH antibody with LH did not inhibit binding of the 
primary antibody and (10 nm) gold-conjugate to the FSH containing secretory granules. 
Bar = .5 pm.
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Figure 3.7. LR Gold-embedded pony pituitary tissue. Cells were double-stained for LH 
and FSH. LH (10 nm, arrows) and FSH (6 nm, arrow heads). Bar = .7 pm.
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%
Figure 3.8. Double-stained equine pituitary cells processed with LH and FSH antibodies. 
LH (10 nm, arrows) and FSH (6 nm, arrow head). Bar = .5 pm.
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Figure 3.9. Ultrastructure of pituitary cells stained only for FSH. Immunogold (10 nm), 
single-stained FSH cell. Note the round nucleus (N), large polymorphic granules (small 
arrow), smaller granules (large arrow) at the periphery of the cytoplasm, and dilated RER 
(*). The granules in the adjacent cell (AC) are not stained immunocytochemically. Bar = 
2 pm.
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Figure 3.10. Ultrastructure of Epon-embedded gonadotropes in the equine pituitary. 
Note the dilated RER (*), large polymorphic granules (arrow heads), smaller secretory 
granules (large arrows) at the periphery of the cytoplasm, mitochondria (m), lysosome 
(L), Golgi complexes (G), and the nucleus (N). Bar = 3 pm.
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Figure 3.11. Immunogold-stained FSH cell in the equine pituitary. Second antibody 
conjugated to 10 nm gold particles was used to detect specific binding of FSH antibody. 
Note the vacuolated cytoplasm (*) with the small granules (large arrow) in the periphery 
and large granules (small arrow) away from the cell membrane. In LRG embedded 
pituitary tissue, the secretory granules of gonadotropes counter-stained with uranyl 
acetate and lead appeared less dense than the secretory granules in other cells. The 
adjacent cell (AC) is a presumptive somatotrope. Bar = 1 pm.
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Figure 3.12. Immunogold-stained FSH cell in the equine pituitary. Second antibody 
conjugated to 10 nm gold particles was used to localize binding of anti-FSH. Note the 
vacuolated cytoplasm (*) with the small granules (large arrow) in the periphery and large 
granules (small arrow) away from the cell membrane. The nucleus of an adjacent cell 
(AC) with its small secretory granules devoid of immunoreactive staining is visible. Bar 
= 2 pm.
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Figure 3.13. Immunogold-stained LH cell in a pony pituitary. Immunogold (10 nm) was 
used to label bound LH antibody. Note the vacuolated cytoplasm (*) with the small 
granules (large arrow) in the periphery and the very large polymorphic granules (small 
arrow) away from the cell membrane. The adjacent cell (AC) with its non-ir granules is 
visible. Also note that the granules in AC are more electron dense than granules in the 
gonadotrope. Bar = 2 pm.
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generally located along the periphery of the cell (Figures 3.10-3.13). The secretory 
granules in LRG-embedded gonadotropes appeared less electron dense than the secretory 
granules in other cell types (Figures 3.11, 3.13). However, electron density was similar 
among granules in all cell types processed with routine Epon-Araldite fixation 
(Figure 3.10). In double-labeled sections, some cells stained with many gold particles 
related to specific-binding for one gonadotropin antibody and a limited number of gold 
particles related to the second gonadotropin antibody (Figure 3.14).
Cell Numbers and Reproductive Status of the Mares. Based on structures on 
the ovaries and serum progesterone levels (Table 3.1) it was apparent that the animals 
were in different stages of the estrous cycle. Pony A was estimated to be in the follicular 
phase of the estrous cycle. Ponies B and C were estimated to be in the mid- to late luteal 
and early follicular phase of the cycle, respectively.
Total number of pituitary cells counted per animal using ten grids as well as the 
percentage of each cell type (LH-only, FSH-only, and cells immunoreactive to both LH 
and FSH) are presented in Table 3.2. The total population of pituitary cells staining for 
both LH and FSH ranged from 15 to 32%. For the three mares included in this study, the 
range for various ir-gonadotropes as a percentage of the total number pituitary cells 
counted was as follows: LH, 2 to 16%; FSH, 1 to 5%; and LH/FSH, 6 to 24%. 
Discussion
Results form the present study show that combining formaldehyde-based tissue 
fixation with low concentrations of glutaradehyde and subsequent embedding in LRG at 
low temperature enabled us to preserve the antigenicity of the gonadotropins and the
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Figure 3.14. Double-stained gonadotrope in a pony pituitary. Note that this cell is 
predominantly a FSH-containing cell, because most of the granules in this cell are stained 
for FSH (6 nm, arrow head) whereas a very small amount of LH (10 nm, arrow) is found 
in these granules. Bar = .3 pm.
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Right ovary Left ovary Plasma
Progesterone
(ng/ml)
A 8/3/95 20 mm follicle 40 mm follicle 1.5
B 5/4/94 45 mm follicle 
28 X 25 mm CL
40 mm follicle 33.8
C 5/4/94 25 mm follicle 12 mm follicle 2.1
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Table 3.2. Relative proportion of the LH and/or FSH containing cells in equine anterior 
pituitaries.
Pony Total cells % L H */• FSH % Both % Total
A 178.0 15.7 4.5 6.2 26.0
B 149.0 2.0 1.3 12.0 15.4
C 100.0 7.0 1.0 24.0 32.0
Average 142.3 8.9 2.3 14.0 24.4
Percentages are calculated by dividing the number of ir-cells by the total number of 
pituitary cells counted in a sample. Only cells with a nucleus were counted.
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ultrastructural morphology. Processing of human pituitary with routine Epon embedding 
techniques allowed Asa et al. [3.23, 3.24] to obtain binding of primary anti-gonadotropin 
antibodies and secondary gold-conjugates to secretory granules in gonadotropes. 
Immunocytochemical staining of Epon-embedded equine pituitary samples was attempted 
but this approach did not allow us to obtain labeling (data not shown). This is probably 
either due to sensitivity of the LH and FSH molecules to high concentration of 
glutaraldehyde or the OsO  ̂fixation. Dacheux [3.25] previously reported that OsO^ 
diminished immunoreactivity of FSHP subunit but not LHP subunit in the pig pituitary. 
The OSO4 fixation did not abolish antigenic activity ofLHp subunit in bovine [3.26] and 
ovine pituitary [3.27] but strongly diminished the immunoreactivity of FSHP subunit. 
Also, in this study, when gold-conjugated IgG was replaced by gold-conjugated protein 
A no staining of equine pituitary tissues was obtained.
The present electron microscopic immunocytochemical study on ultrathin sections 
permitted ultrastructural characterization of gonadotropes within the equine anterior 
pituitary and provided preliminary data on subsets of cells containing ir-LH and/or FSH. 
Some cells contained granules labeled for both LH and FSH; this demonstrates that the 
two hormones may be stored in the same granules and perhaps released simultaneously 
from a subset of equine gonadotropes. This study has also shown, based on visual 
observation, that the concentrations of ir-FSH and LH can vary from cell to cell, and that 
some cells contain only FSH or LH. These cells represent two additional subsets of 
equine gonadotropes. However, the possibility cannot be excluded that these cells do
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contain quantities of co-localized LH or FSH that can not be detected with 
immunocytochemistry.
These results indicate, for the first time, that gonadotropes in the equine pituitary 
can be divided into FSH-only, LH-only, and cells containing both ir-LH and FSH. Our 
results are in agreement with results from light and electron microscopic studies of other 
mammalian species [3.6-3.12]. Although Basting et al. [3.13] reported that the bovine 
anterior pituitary lacks the cell type that stores both LH and FSH simultaneously, we 
have processed pituitary tissue from steers in the same manner (data not shown) as our 
equine pituitaries, and found LH and FSH co-localized in many cells just as in the equine 
pituitary. The reason for the discrepancy between their results and ours is not clear, but 
it could be due to the use of different reagents and embedding resin in the two studies.
Plasma progesterone concentrations and ovarian structures at the time of 
slaughter suggest that these mares were in different stages of the cycle (i.e., under 
different hormonal milieu). If the cell counts obtained from our three ponies are indeed 
representative of mares in the various stages of the estrous cycle, we would speculate 
that the relative abundance of the subsets of equine gonadotropes may be influenced by 
the hormonal milieu of the animal. Whether or not this possibility is applicable to the 
equine species will obviously require experiments with more mares in defined stages of 
the estrous cycle. However, these experiments are justified since progesterone has been 
shown to inhibit the synthesis of LH secretion [3.22] and it is possible that progesterone 
also plays a role in regulating the LH-producing cell populations in pony mares (Table 
3.2). A possible role for estradiol in regulation of gonadotrope subset can not be ruled
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out by this experiment. It is known that estradiol has a positive effect on LH synthesis 
and secretion in equine pituitary [3.22]. This could contribute to the higher percentage of 
ir-LH cells in pony A and C. However, a light microscopic study in sheep [3.12] 
indicated that the relative percentages of gonadotropes were not influenced by the stage 
of the estrous cycle.
Gonadotropes comprised 10 to 15% of sheep pituitary cells and this population 
included a subset of cells that stained for both gonadotropins (57% of gonadotropes) and 
about 34% and 8% of the gonadotropes stained only for LH or FSH, respectively [3.12]. 
In OVX ewes, 75% of the gonadotropes stained for both hormones, 22% stained only for 
LH, and 3% stained only for FSH [3.12]. In OVX rats, 75-85% of the gonadotropes 
stained for LH and FSH and about 20% of the cells stained for only one gonadotropin 
[3.8]. In pigs, 21 to 25% and 24 to 37% of the gonadotropes contained both ir- 
hormones in intact and OVX animals, respectively [3.25]. In this study, gonadotropes 
comprised on the average about 24% of the pituitary cells and this cell group was further 
subdivided into 2 to 16% LH-only cells, 1 to 5% FSH-only cells, and 15 to 32% dual 
hormone containing cells.
In conclusion, post-embedding immunocytochemistry methods using immunogold 
labeling and specific LH and FSH primary antibodies has proven to be a practical 
approach to characterize the distribution of ir-gonadotropins and ultrastructure of subsets 
of ir-gonadotropes In the equine pituitary. Results from this experiment have also 
demonstrated that the ’’one cell-one hormone” concept does not apply to a certain 
populations of gonadotropes in the horse pituitary. Preliminary data in this experiment
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suggest that physiological and endocrinological effects on subclasses of gonadotropes
may provide information on pituitary cell groups affected by feedback from the gonads.
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CHAPTER IV
EFFECTS OF ESTRADI0L-I7p AND DIHYDROTESTOSTERONE ON 
GONADOTROPES IN EQUINE PITUITARIES:
AN IMMUNOCYTOCHEMICAL STUDY
Introduction
There are numerous reports on the effects of reproductive steroids on production, 
secretion, and storage ofLH and FSH in the equine species [4.1-4.17], It is also well 
established that LH and FSH content of the pituitary is profoundly influenced by 
reproductive steroids [4.9, 4.13, 4.18]. Thompson and coworkers [4.17] previously 
evaluated the relationship between hormone secretion and storage and pituitary response 
to secretagogue after steroid treatment of OVX pony mares. These authors concluded 
that estradiol had a positive effect on LH secretion and storage whereas it had a negative 
eftect on FSH secretion. However, estradiol increased FSH storage in the pituitary gland. 
Androgen treatment of the ponies lowered LH secretion and storage and reduced FSH 
secretion while increasing its storage.
Ultrastructural studies of gonadotropes have been reported for dogs [4.19], mice 
[4.20], rats [4.21-4.23], pigs [4.24], humans [4.25], and sheep [4.26]. These studies 
have indicated that there are three classes of gonadotropes, including cells that contain 
and secrete either FSH or LH and cells that contain and simultaneously secrete both LH 
and FSH. Similar results have been obtained for pituitary tissues of intact pony mares 
[4.27]. Light microscopic study of sheep pituitaries by Ginal and Nett [4.26] suggested 
that the number of gonadotropes in the pituitary did not change during the estrous cycle.
73
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Nevertheless, ovarian steroids are known to influence the secretion and storage of the 
gonadotropins in the horse pituitary gland [4.1-4.4, 4.7, 4.12, 4.13,4.16]. The question 
arises whether alterations in gonadotropins may be related to changes in the number of 
immunoreactive (ir)-gonadotropes or whether there is merely an alteration in cell content 
of gonadotropins. It is also not known whether all of the three types of gonadotropes in 
equine pituitaries are regulated similarly by the gonads and/or individual gonadal steroids. 
It may be that there is a difference in the responsiveness of a gonadotrope subset to 
various secretagogues and peripheral hormones. The objective of the present study was 
to determine if the ultrastructure, ir-staining properties, and/or numbers of cells in each 
subset of the gonadotrope population in OVX pony mares change when animals are 
subjected to long-term treatment with estradiol or dihydrotestosterone (DHT).
Materials and Methods
Animals and Treatments. Twelve adult (6 to 12 years of age) long term (>2 
years) OVX pony mares weighing between 168 and 323 kg were kept on pasture and fed 
grass hay as needed to maintain good body condition. The mares were randomly 
assigned to one of three treatment groups (n = 4/group). Group 1 (C) was injected with 
1 ml of com oil. The oil was also used as a vehicle for treatment administration to 
Groups 2 and 3. Group 2 received 35 pg/kg of bodyweight per day of estradiol (Sigma 
Chemical Co., St. Louis. MO) and Group 3 received 150 pg/kg of bodyweight per day of 
DHT (Sigma Chemical Co.). All injections were given subcutaneously in the neck 
region. Treatment injections were repeated daily at 0800 for 21 days immediately after 
the daily blood samples were drawn. Due to the time needed for processing tissues for
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electron microscopy and RIA, the starting days for injections were staggered over four 
consecutive days so that pituitaries of only three animals, one from each treatment group, 
were collected for processing on day 22 when the animals were sacrificed. The injections 
were started and tissues processed between July 11 and August 4, 1994.
Daily blood samples were collected via jugular venipuncture immediately prior to 
the daily injections. These samples were drawn into heparinized tubes; plasma was 
harvested by centrifugation, and samples stored at -15°C for later analysis.
Pituitary Preparation for Hormone Analysis, The pituitaries were removed 
within 7 to 12 min following euthanasia by electrocution. Tissues were rinsed with saline 
and cut mid-sagittaly. One half of each pituitary was placed in ice-cold .01 M phosphate 
buffered saline (.15 M NaCl; PBS). Tissues were stripped of the surrounding capsule, 
the neural lobe was separated from the anterior pituitary (AP), and the halved AP was 
weighed. This AP sample was homogenized in 100 ml of PBS in a Waring 7011 blender 
(Waring Prod. Div., Dynamics Corp. of America, New Hartford, CT) at maximum setting 
for 30 sec. Another 100 ml of PBS was used to rinse out the blender. The homogenates 
were mixed well and 10 ml aliquots were centrifuged at 1200 x g for 30 min at 4“C. The 
supernatants were harvested and frozen at -20°C. Pituitary homogenates were diluted 
1:500 in PBS containing 0.1% (w/v) gelatin. Concentrations of LH and FSH in plasma 
samples and pituitary homogenates were measured by RIA as described previously [4.28, 
4.29].
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Tissue Preparation for Electron Microscopy. Following a rinse with saline, 
the other half of AP was placed in freshly prepared 4% formaldehyde (Electron 
Microscopy Sciences, Fort Washington, PA) plus 0.1% glutaraldehyde (Polysciences, 
Warrington, PA) buffered with 0.1 M sodium cacodylate (pH 7.3; Electron Microscopy 
Sciences). While in the fixative, the pituitaries were fi'eed of the surrounding capsule and 
the AP was removed fi'om the neural lobe. The pituitary tissues were then cut into 
approximately I mm  ̂pieces and fixation continued for 2 h. Some of the tissue blocks 
were processed for routine Epon-Araldite electron microscopy as previously described by 
Poolsawat [4.30]. Following fixation, ten randomly selected pieces from each animal 
were removed and cut into smaller pieces; these were used for embedding. Tissues were 
washed several times in 0.1 M sodium cacodylate buffer to remove any residual aldehyde. 
Tissues were then dehydrated in 50% ethanol (EtOH) for 15 min, 70% EtOH for 20 min 
and 90% EtOH for 30 min. Tissues that were going to be immunocytochemically stained 
were infiltrated and then embedded with 60% LR Gold (LRG; Electron Microscopy 
Sciences) monomer : 40% EtOH for 30 min; 70% LRG : 30% EtOH for 30 min; 100% 
LRG monomer for 2 h; 100% LRG monomer plus 0.1% benzil (initiator) for 2 h; and 
finally overnight in 100% LRG monomer plus initiator. All procedures were performed 
at room temperature. The tissues were then embedded in small gelatin or large BEEM* 
capsules (Electron Microscopy Sciences). The LRG was polymerized under UV light at - 
15‘’C for 24 to 36 h. Ultrathin, 80-90 nm light gold-colored sections were cut on a 
Sorvall MT2-B ultramicrotome and sections were mounted on 400 mesh gold grids.
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Immunogold Labeling. Sections were first incubated for 10 min on a drop of 
0.05 M Tris (pH 7.3) containing 0.02 M glycine to quench any aldehyde left in the tissue. 
They were then incubated on a drop of Tris buffer containing 1% BSA plus 10% normal 
goat serum (blocking solution) to reduce non-specific binding. The grids were then 
transferred to a 35 pi drop of the primary antibody (diluted 1:20 in the blocking solution). 
Sections were incubated with characterized primary antibodies [4.27] for 2 h. Next, grids 
were blotted and rinsed four times on a drop of Tris buffer for 5 minutes each. Then the 
sections were blotted and transferred to a drop of the blocking solution for 5 min. They 
were then transferred to a 35 pi drop of a 20% solution (as recommended by the 
supplier) of goat anti-rabbit IgG gold conjugate (Electron Microscopy Sciences) and 
incubated for 50 min. The size of the gold particles used were 6 or 10 nm. The sections 
were then washed in Tris buffer with 2.5 M NaCl for 10 min, rinsed in distilled water, and 
dried. The final step involved incubating the sections on a drop of a 0.5 % formaldehyde 
for 10 min and rinsing with distilled water followed by complete drying.
Double-labeling was done following a protocol described previously by Bendayan
[4.31]. Briefly, following the above steps for one side of the grid, the grid was turned 
over and the same procedure was followed except that the primary antibody and the size 
of the gold particle conjugated to the secondary antibody were changed. The sections 
were counter-stained with uranyl acetate and modified Sato lead before examination with 
a Philips 410 Electron Microscope. In addition to the cross-reactivity procedures, other 
controls consisted of omitting the primary antibody step and testing for
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immunocytochemical staining of tissues processed with primary antibodies pre-absorbed 
with various purified pituitary hormone preparations.
Statistical Analysis. Data consisting of repeated measurements taken over time 
were analyzed by ANOVA that accounted for the repetitive nature of the sampling. 
Hormonal concentrations in daily samples were calculated as a percentage of the 
pretreatment concentrations before analysis. The least significant means (LSM) test was 
used to compare post-treatment means to data for the pretreatment samples. Non- 
repetitive data were analyzed by one-way ANOVA and means for each treatment were 
compared to controls by the LSM test. All data were analyzed on PC-S AS version 6.11
[4.32].
Results
Daily Hormone Concentrations. Day 1 pretreatment gonadotropin 
concentrations (means ± SE) were: Group 1/vehicle-treated, LH = 7.2 ± 1.7 ng/ml, FSH 
= 65.6 ± 25.3 ng/ml; Group 2/estradiol-treated, LH = 6.4 ± 2.0 ng/ml, FSH = 51.1 ± 30.0 
ng/ml; Group 3/DHT-treated, LH = 9.4 ± 5.0 ng/ml, FSH = 70.8 ± 12.5 ng/ml. Plasma 
LH concentrations, in vehicle- and estradiol-treated ponies did not change (P > .1) over 
time (Figure 4. la). There was a significant (P < .001) difference in gonadotropin 
concentrations measured in the three treatment groups. Treatment with DHT reduced (P 
< .0001) LH secretion by the end of the treatment period.
Plasma concentrations of FSH in vehicle-treated ponies did not vary (P > .1) from 
pretreatment levels during the twenty one-day period. Treatment with DHT and estradiol 
reduced (P < .05) plasma FSH concentrations (Figure 4.1b).






Figure 4.1. Mean daily plasma concentrations ofLH (a) and FSH (b) as a percentage of 
the pretreatment value for mares administered oil, estradiol, or DHT. Mares were 
administered oil (C), estradiol (E), and DHT daily for 21 days. Data were analyzed by 
analysis of variance.
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Hormone Content in the Pituitary. Pituitary content ofLH and FSH in steroid- 
treated OVX mares are presented in Figure 4.2. One animal in the control group had 
extremely high values for LH and FSH. Statistical analysis determined that this animal 
was an outlier (P < .01). Therefore, data from the other three mares in the control group 
were used to determine treatment effects on pituitary content ofLH and FSH. Treatment 
with DHT caused a reduction (P < .05) in pituitary LH content. Estradiol treatment 
significantly (P < .05) increased LH content compared to DHT- and vehicle-treated 
animals. Pituitary content of FSH was not influenced (P > .1) by treatment with DHT. 
However, estradiol caused a significant (P < .05) increase in the concentrations of FSH in 
the pituitaries.
Pituitary Cell Counts. The number of cells which stained only for LH or FSH 
and the number of cells containing both ir-gonadotropins are listed as a percentage of the 
total number of cells in Table 4.1. Total number of cells counted for each treatment 
group were; Oil, 512; estradiol, 657; and DHT, 648. There was no treatment effect (P >
. 1) on the number of cells staining only for LH. However, there was a significant (P < 
.05) treatment effect on cells staining only for FSH and cells containing both LH and 
FSH. Treatment with DHT reduced (P < .05) the number of cells stained for both 
hormones as compared to double-labeled cells in the estradiol-treated and the control 
group. Tissues from animals treated with DHT also had more (P < .05) cells which 
stained only for FSH. In all three treatment groups cells containing only ir-LH 
constituted a very small percentage of the total cell population. Estradiol did not affect 
(P > .1) the population of cells immunoreactive for both gonadotropins when compared














Figure 4.2. Pituitary content ofLH and FSH in control and steroid-treated OVX pony 
mares. Mares were treated with oil (C), estradiol (E), or DHT daily for 21 days. 
Estradiol significantly (P < .05) increased pituitary LH and FSH content compared to C- 
and DHT-treated mares, a, b, c: Mean with different letters were significantly (P < .05) 
different.
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Table 4.1. Mean (M) and relative percentage (%) of ir-LH, ir-FSH and ir-LH/FSH 
(Both) stained cells in steroid- or vehicle- (Control) treated OVX pony mares.
Control Estradiol DHT
Cell type M '(% ) M '(% ) M*(%)
LH 1.8 (1.4)3 1.3 (0.8)3 1.0 (0.6)3
FSH 2.3 (1.8)3 6.8 (3.2)3 14.5 (9.0)3
Both 11.5(9.0)" 12.8 (7.8)" 5.3 (3.2)3
Total 15.5 (12.1)« 20.8 (11.7)« 22.8 (12.4)®
"Means represent average number of cells counted per grid (10 grids were counted for 
each horse).
The SE for mean values ofLH, FSH, and Both were 1.0, 2.2, and 2.0, respectively.
Different superscripts in each row indicate a significant (P < .05) difference in 
mean values within that row.
Percentages are calculated by dividing the number of ir-cells by the total number of 
pituitary cells counted. Total number of cells counted for each treatment group were: 
Oil, 512; estradiol, 657; and DHT, 648.
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to the control group. The percentage of pituitary cells which were gonadotropes was not 
influenced (P > .1) by different steroid treatments.
Ultrastructural Morphology of Gonadotropes. In Epon-embedded pituitary, 
gonadotropes from the vehicle-treated OVX pony mares were extremely vacuolated and 
they contained a small number of secretory granules scattered throughout the cytoplasm 
(Figure 4.3). Vacuolation of the cytoplasm was also seen in LR Gold-embedded pituitary 
tissues (Figure 4.4). Mitochondria were generally long and slender and were found in 
close proximity o f each other in the cytoplasm (Figures 4.5, 4.6). The subset of 
gonadotropes stained for both gonadotropins in the DHT-treated group was 
predominantly stained for ir-FSH (Figure 4.6).
Biological Activity of Estradiol-1 Estradiol did not affect LH secretion 
based on plasma LH and the number of ir-LH-producing cells in the pituitary. Thus, the 
biological activity of estradiol used for treatment injections was questioned. A uterine 
bioassay was used to assess bioactivity of the estradiol used in this experiment. Eight 
immature rats (25 days old) were divided into four groups (2/group) which received a 1 
ml injection of com oil (vehicle) or 100 pg, 10 pg, or 1 pg of estradiol in vehicle. Six 
hours later the uteri of the animals were excised and weighed. The estradiol used in this 
experiment caused a significant (P < .05) increase in uterine weight and therefore it was 
biologically active. The results are summarized in Table 4.2.
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Figure 4.3. Epon-embedded pituitary tissue of an OVX pony mare treated with oil. Note 
the degree of vacuolization. Small secretory granules (arrows) are scattered throughout 
the cytoplasm. Lysosomes (L). Nucleus (N). Bar = 5 pm.
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Figure 4.4. LR Gold-embedded pituitary tissue of an OVX pony mare treated with oil. 
The cytoplasm is highly vacuolated (*) with a small number of scattered granules. 
Adjacent cell is a presumptive somatotrope. Bar = 2 pm. Inset: An enlarged area of the 
cytoplasm with labeled granules. This cell is labeled primarily for FSH and it contains 
relatively less immunogold conjugate associated with LH-specific primary antibody (FSH 
= 6 nm immunogold, arrow head; LH = 10 nm , arrow). Bar = .2 pm.
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Figure 4.5. LR Gold-embedded pituitary tissue of an OVX pony mare treated with oil. 
Note the vacuolization (*) of the cytoplasm along with the low number of secretory 
granules. Mitochondria (M) are generally long and slender. Nucleus (N). Bar = 1 pm.
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Figure 4.6. Characteristic appearance of double-labeled gonadotropes in OVX pony 
mares treated with DHT. LH =10 nm, arrows; FSH = 6 nm, arrow heads. Note that the 
granules are predominantly stained for FSH. Bar = 1 pm.
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Table 4.2. Mean uterine weight in rats treated with different amounts of estradiol.
Estradiol Uterine wt (mg ± SE)
100 Jig 0.11‘ ±.020
10 fig 0.1‘ ±.010
1 Rg 0.07^ ±.003
C 0.07^ ±.002
1.2 Different superscripts indicate a significant (P < .05) difference.
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Discussion
Farquhar and Rinehart [4.33] reported that gonadotropes in gonadectomized rats 
have a “signet-ring” shape. However, in this study we did not observe any equine 
gonadotropes with cellular characteristics of signet cells.
There are conflicting reports on the affects of androgens on gonadotropin 
synthesis and the pituitary concentrations of gonadotropin subunits and the related 
mRNAs. In vivo studies, in rats, have shown that androgens negatively regulated only a 
and LHp subunit mRNA levels, having little or no effect on FSHP subunit mRNA levels 
[4.34-4.36], Gharib et al. [4.37] reported that in vitro treatment of rat pituitary cells 
with androgens positively regulated FSHP subunit mRNA levels but has no effect on a  or 
LHP subunit mRNA levels. In other reports, testosterone treatment of adult castrated 
rats resulted in an increase in pituitary content of FSH, but a decline in LH content 
[4.38]. Publications have also claimed that the differential in vivo regulation of 
gonadotropin synthesis occurs at the transcription level in both male and female rats 
[4.34- 4.36, 4.39]. Organ cultures of adult female pituitaries, when treated with DHT for 
5 days, have increased stores of FSH but markedly decreased stores of LH [4.40]. The 
effects of DHT on LH and FSH also reportedly include reduced LH and FSH secretion, 
increased pituitary content of FSH, and reduced pituitary content ofLH [4.10, 4.12,
4.13,4.16, 4.17]. In the present study, plasma LH and FSH concentrations were reduced 
in DHT-treated animals; this reduction was related to lower pituitary concentration of 
LH, but the reported positive effect of DHT on FSH was not seen at the pituitary level. 
The reason for the lack of effect of DHT on pituitary FSH concentration is not clear.
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However, based on the above findings, we can probably deduce that DHT treatment of 
OVX pony mares inhibited LH synthesis or increased LH degradation in ir-LH cells, 
thereby reducing concentrations and the releasable pool o f LH. In support of this 
possibility, the reduced staining for LH in double-labeled cells suggests that treatment of 
OVX pony mares with DHT inhibited LH production or increased LH degradation. 
Furthermore, the reduction in the number of cells staining for both gonadotropes is 
probably due to an inhibitory effect of DHT on ir-LH in gonadotrope subsets that 
normally stain for both gonadotropins.
Despite the lack of a DHT affect on FSH content in the pituitary in this study, the 
number of cells containing FSH increased in DHT treated group. Gonadotropes in DHT- 
treated animals primarily stained for FSH and very few cells which stained only for LH 
were counted. Nevertheless, the percentage of pituitary cells that were stained as 
gonadotropes did not change following DHT treatment. Therefore, we believe 
that any increase in FSH-only cells is probably due to an inhibition of ir-LH detected by 
immunocytochemistry and not division of the FSH-only cell numbers. This might also 
suggest that androgens have a more profound effect on ir-LH than FSH and that they 
selectively act on the subset of gonadotropes that contains both ir-gonadotropins.
Estradiol increased LH content of the pituitary. However, this increase was 
neither reflected in the concentrations of estradiol in blood samples or the number of cells 
stained only for LH. Previous studies have shown that administration of estradiol to 
OVX mares results in a significant increase in plasma LH concentration and the pituitary 
content ofLH [4.17]. However, estradiol-treated animals in the present study had
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decreased plasma FSH concentrations and a moderate increase in the pituitary FSH 
content. Furthermore, the estradiol used in this study tested positive when used in a rat 
uterine bioassay. Therefore, there is no doubt that the estradiol given to these animals 
was biologically active. The reason as to why estradiol did not increase plasma LH in the 
OVX mares is not clear. However, estradiol may not have elicited a positive response in 
LH release since these ponies were OVX more than two years prior to the beginning of 
this study and LH producing cells in the pituitary and/or estrogen-sensitive loci in the 
brain may have become unresponsive to the stimulatory effects of estradiol at the dosage 
used. Perhaps due to the long-term ovariectomy, the amount of estrogen used increased 
LH synthesis or reduced LH degradation without affecting the release ofLH or the ir- 
staining of this gonadotropin.
Exogenous estradiol and DHT were measurable in the plasma samples in the 
study with OVX pony mares done by Thompson et al. [4.17]. However, levels of these 
steroids were undetectable in the present study. The estradiol used in this study was 
suspended in com oil. Solid vegetable shortening was used by Thompson et al. [4.17] as 
a vehicle to deliver steroid treatments. There is the possibility that crystalline estradiol 
and DHT were released at a more gradual rate from the solid shortening whereas the 
release from the com oil was more rapid. Thus, estradiol and DHT treatments used in 
this experiment may not have provided the same duration of increased levels of plasma 
estradiol and DHT. Another possible reason as to why more ir-LH cells were not 
detected despite an increase in pituitary LH could be that the newly synthesized LH 
molecules were not detected by our immunocytochemistry technique. The antigenic
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specificity of polyclonal antibody against protein hormones may differ for 
radioimmunoassay and immunocytochemistry [4.41]. Further studies using techniques 
such as reverse hemolytic plaque assay and mRNA measurement might help to clarify the 
discrepancy in steroid affects on pituitary and plasma concentrations ofLH.
When unstimulated, the percentage of ir-LH and ir-FSH cells in the pituitary seem 
to be relatively equal and lower than the number of cells that are immunoreactive for both 
gonadotropins. Steroid feedback may alter the ratio of cells staining for individual or 
both gonadotropins without changing the total number of gonadotropes. This suggests 
that most equine gonadotropes have the capability to store both gonadotropins and that 
this subset of cells is most sensitive to steroid feedback. The two cell fractions which 
stained only for LH or FSH may contain low or undetectable levels of the alternate 
gonadotropin. Nevertheless, the equine pituitary does indeed contain three ir- 
gonadotrope subsets. Cells that stained for LH-only were not affected by steroid 
treatment. However, cells that stained for FSH-only and for both LH and FSH were 
affected by steroid treatment.
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CHAPTER V
IMMUNOCYTOCHEMICAL LOCALIZATION OF PROLACTIN AND 
GROWTH HORMONE IN THE EQUINE PITUITARY
Introduction
Immunoperoddase and immunogold labeling techniques have been used to 
identify cells that produce growth hormone (GH) and prolactin (PRL) in normal tissue 
and in pituitary tumors in monkeys [5.1], humans [5.2-5.S], rats [5.6-S.9], hamsters 
[5.10, 5.11], pigs [5.12], goats [5.13], cows [5.14-5.17], sheep [5.18-5.20], and musk 
shrews [5.21-5.23]. Tashjian and coworkers [5.24] suggested that the production of 
both GH and PRL from one cell type occurs in rodent pituitary tumors. Zimmerman et 
al. [5.25] reported that certain areas of normal human pituitaries contain numerous cells 
that stain for both GH and PRL and these cells represented more than 50% of the total 
number of cells in the anterior pituitary. These investigators concluded that a significant 
population o f cells normally contain both of these hormones in human pituitaries. More 
recent investigations utilizing immunocytochemical techniques at the electron 
microscopic level have supported the conclusion that PRL and GH normally co-exist in 
cells of adult and fetal human pituitaries [5.26-5.28], human pituitary adenomas [5.5,
5.25, 5.29-5.32], and normal rat [5.33, 5.34] and cow [5.16, 5.17] pituitaries, and are 
referred to as mammosomatotropes. Moreover, hemolytic plaque assays of cells from 
normal and tumorous rat and human pituitaries, as well as cow pituitary cells in culture, 
have shown that mammosomatotropes can secrete PRL and GH simultaneously [5.35- 
5.37].
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We previously reported [5.38] light microscopy results for immunocytochemically 
stained pituitary glands collected from ponies. That study enabled us to dififerentiate cell 
types and to determine the distribution of different pituitary cell types in the equine 
species. The light microscopic technique, however, only provided a coarse localization 
of hormones and a general distribution of the cell types that stained for a single hormone. 
A more precise labeling method was necessary to clearly delineate the ultrastructural 
characteristics of lactotropes and the somatotropes and to determine whether 
immunoreactive (ir) hormones are co-localized in pituitary cell populations in the equine 
species. Thus, the objectives of the present study were to: 1) identify and differentiate 
lactotropes and somatotropes at the ultrastructural level; 2) determine whether PRL and 
GH are contained within separate cell populations; 3) determine whether the equine 
pituitary contains mammosomatotropes; and 4) characterize the relative abundance of the 
lactotropes, somatotropes, and mammosomatotropes in the equine pituitary.
Materials and Methods
Pituitary Fixation And Embedding. Three adult pony mares were used for this 
experiment. The mares were kept on pasture and were fed grass hay as needed to 
maintain good body condition. They were sacrificed by electrocution and the pituitaries 
were removed within 7-12 min. Presence of any follicles and/or corpus luteum on the 
ovaries were recorded and a blood sample from each animal was collected in a 
heparinized tube at the time of slaughter for progesterone analysis [5.39]. Pituitary 
tissues were rinsed with saline and fixed by immersion in freshly prepared 4% 
formaldehyde (Electron Microscopy Sciences, Fort Washington, PA) plus 0.1%
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glutaraldehyde (Polysciences, Warrington, PA) buffered with 0.1 M sodium cacodylate 
(pH 7.3; Electron Microscopy Sciences). While in the fixative, the pituitaries were freed 
of the surrounding capsule and the AP was removed fi'om the neural lobe. The pituitary 
tissues were then cut into approximately 1 mm  ̂pieces and fixation continued for 2 h. 
Following fixation, ten randomly selected pieces fi’om each animal were removed and cut 
into smaller pieces; these were used for embedding. Tissues were washed several times 
in 0.1 M sodium cacodylate buffer to remove any residual aldehyde. Tissues were then 
dehydrated in 50% ethanol (EtOH) for 15 min, 70% EtOH for 20 min and 90% EtOH for 
30 min. Some of the tissue blocks were processed for ultrastructural study using routine 
Epon-Araldite embedding and transmission electron microscopy as previously described 
by Poolsawat [5.40]. The tissues processed for immunocytochemical staining were 
infiltrated with 60% LR Gold (LRG; Electron Microscopy Sciences) monomer : 40% 
EtOH for 30 min; 70% LRG : 30% EtOH for 30 min; 100% LRG monomer for 2 h;
100% LRG monomer plus 0.1% benzil (initiator) for 2 h; and finally overnight in 100% 
LRG monomer plus initiator. All procedures were performed at room temperature. The 
tissues were then embedded in small gelatin or large BEEM* capsules (Electron 
Microscopy Sciences). The LRG was polymerized under UV light at -15 ®C for 24 to 36 
h. Ultrathin, 80-90 nm light gold-colored sections were cut on a Sorvall MT2-B 
ultramicrotome and sections were mounted on 400 mesh gold grids.
Primary Antibody Specificity and Cross-Reactivitv. The polyclonal primary 
antibodies used were rabbit anti-porcine (p) PRL [5.41] and rabbit anti-bovine (b) GH 
which was prepared by the late Dr. Choh Hao Li and colleagues (University of California,
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San Francisco) and made available to us by Dr. Harold Papkofif (University of California, 
Davis). Peptides used to test cross-reactivity of these antibodies included: bLH (USDA- 
bLH-B-6), human (h) FSH (hFSH-I-SIAFD-1, Lot # AFP-5720D), pPRL (USDA-pPRL- 
B-1), pGH (USDA-pGH-B-1), bovine thyroid stimulating hormone (bXSH; USDA- 
bTSH-I-1), and hACTH (human ACTH-I-SIAFD-1, Lot # AFP-2938C). These peptides 
were obtained from the National Hormone and Pituitary Program (Rockville, MD). 
Primary antibodies used in this study were previously tested for specific 
immunocytochemical staining of pituitary hormones in free-floating sections processed 
for examination at the light microscopic level [5.38]. In those experiments [5.38], 
primary antibodies were pre-absorbed with immunoglobulin fractions that cross-reacted 
with unrelated pituitary hormones, and the hormones were immobilized on a solid 
support and subsequently processed for immunocytochemical staining with avidin-biotin- 
peroxidase conjugates. In the present study, primary antibodies pre-absorbed of cross­
reactive immunoglobulin fraction were used for post-embedding immunocytochemical 
labeling and examination of tissues at the electron microscopic level. To this end, 10 pg 
of each hormone, in 5 pi of 0.05 M Tris buffer (pH 7.3), was spotted onto nitrocellulose 
paper and allowed to air dry. The immobilized peptides were then exposed to 4% 
formaldehyde vapor for 30 min and incubated with 100 pi of each antibody preparation 
for 50 hours at 4°C. Ultrathin sections were incubated with absorbed primary antibody 
preparations and processed for immunocytochemical staining as described below.
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Immunogold Labeling. Sections were first incubated for 10 min on a drop of 
Tris bufifer, containing 0.02 M glycine to quench any aldehyde left in the tissue. They 
were then incubated for 30 min on a drop of Tris buffer containing 1% BSA plus 10% 
normal goat serum (blocking solution) to reduce non-specific binding. The grids were 
then transferred to a 35 pi drop of the primary antibody (diluted 1:20 in the blocking 
solution). Sections were incubated with diluted primary antibodies for 2 h. Next, grids 
were blotted and rinsed four times on a drop of Tris buffer for 5 min. Then the sections 
were blotted and transferred to a drop of the blocking solution for 5 min. They were 
transferred to a 35 pi drop of a 20% solution (as recommended by the supplier) of goat 
anti-rabbit IgG gold conjugate (Electron Microscopy Sciences) and incubated for 50 min. 
The sizes of gold particles conjugated to secondary antibodies were 6 or 10 nm. Single 
labeling was done with 6 or 10 nm gold conjugated IgG. Sections were subsequently 
washed in Tris buffer with 2.5 M NaCl for 10 min, rinsed in distilled water, and dried.
The final step involved incubating the sections on a drop of a 0.5 % formaldehyde for 10 
min and rinsing with distilled water followed by complete drying.
Double-labeling was done following a protocol described previously by Bendayan 
[5.42]. Briefly, following the above steps for one side of the grid, the grid was turned 
over and the same procedure was followed except that the primary antibody and the size 
of the gold particle were changed. The sections were counter-stained with uranyl acetate 
and Sato lead before examination with a Philips 410 Electron Microscope. In addition to 
the cross-reactivity procedures, other controls consisted of omitting the primary antibody 
step and testing for non-specific binding of the gold particles to the tissue.
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Pituitary Cell Counts. To assess relative cell frequencies, ten grids per animal 
were viewed using transmission electron microscopy. One section per grid was used to 
count cells and to assess binding of the gold particles. Only cells sectioned through a 
nucleus were counted.
Results
Fixation of equine pituitary tissues in 4% cacodylate-bufrered formaldehyde with 
0.1% glutaraldehyde followed by low temperature embedding in LR Gold preserved 
ultrastructural characteristics of the tissue and subcellular organelles within individual 
cells (Figure 5.1). Immunocytochemical staining with the pre-absorbed primary 
antibodies followed by secondary IgG-gold complexed antibodies resulted in specific 
staining which was associated with the secretory granules (Figures 5.2, 5.3). Thus, the 
fixation and embedding procedures were compatible with retention of antigenic sites 
associated with primary antibody binding to PRL and GH.
Specificity of the Antibodies. Gold-conjugated secondary antibodies did not 
bind to secretory vesicles when primary antibodies were omitted (Figure 5.4). 
Furthermore, gold-conjugated secondary antibody did not bind when the primary 
antibodies were pre-absorbed by the homologous pituitary hormone (Figures 5.5, 5.6). 
Immunocytochemical staining with anti-bGH and anti-pPRL antibodies was not abolished 
or visibly reduced when primary antibodies were pre-absorbed with heterologous 
antigens (Figures 5.2, 5.3 inset). Results from tests on absorbtion of anti-GH and anti- 
PRL antibodies with bLH, bTSH, oFSH, and hACTH are not shown; however, these 
protein hormones did not visually affect immunocytochemical staining for GH or PRL.
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Figure 5.1. Pony pituitary tissue embedded in LRG showing a relatively well preserved 
somatotrope. Note that the small granules (arrow) in the adjacent cell are labeled for 
prolactin (6 nm immunogold; arrows). Rough endoplasmic reticulum (*), nucleus (N). 
Bar = 3 pm.
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Figure 5.2. Characteristic ultrastructure and staining of Type I lactotropes in sections 
treated with anti-PRL antibody which were pre-absorbed with GH. Type I lactotrope 
cytoplasm stained with 10 nm gold particles. GH did not inhibit specific 
immunocytochemical staining of lactotropes. Note the variety in shapes of the lactotrope 
secretory granules, including a rod shaped one (arrow). Bar = .5 pm.
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Figure 5.3. Typical morphology of somatotropes in sections treated with anti-GH 
antibody pre-absorbed with PRL. The somatotrope is labeled with 10 nm gold particles. 
Prolactin did not inhibit immunocytochemical staining of somatotropes. Note the 
uniformity in shapes of the secretory granules. Bar = 1 pm. Inset: An enlarged area of 
the cytoplasm. Bar = .5 pm.
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Figure 5.4. Somatotrope secretory granules in a pony pituitary. Only background 
binding of gold particles was observed following the omission of the primary antibody. 
Bar = .5 pm.
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Figure 5.5. An enlarged area of cytoplasm in a somatotrope. The sections were treated 
with anti-GH antibody absorbed with GH. Only background binding of gold particles 
was found in these sections observed. Bar = .5 pm.
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à
Figure 5.6. Type I lactotrope cytoplasm in sections which were treated with anti-PRL 
antibody pre-absorbed with PRL. Only background binding of gold particles was 
observed. Bar = 5 pm.
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Figure 5.7. Ultrastructure of a mammosomatotrope in the pony pituitary: Double- 
labeling for PRL and GH in secretory granules. PRL = 6 run, large arrow; GH= 10 nm, 
small arrow. Bar = .25 pm.
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Therefore, pituitary ceils stained with anti-GH antibody can be considered as GH 
containing-cells, cells stained with anti-PRL antibody as PRL containing-cell, and cells 
stained with both antibodies are considered to be mammosomatotropes (Figure S.7).
Ultrastructural Morphology of the ir-PRL and ir-GH Cells. Pituitary cells 
labeled with anti-PRL antibodies were classified into two morphological subsets based on 
the size of secretory granules and cell size. Type I lactotropes commonly had eccentric 
nuclei, contained numerous large and dense polymorphic granules, and contained some 
rod shaped granules (Figures 5.2, 5.8). These cells had a large cytoplasmic volume 
relative to the size of the nucleus. Type I lactotropes were also readily recognizable at 
the ultrastructural level due to the characteristic morphology of the secretory granules. 
Type n  lactotropes (Figures 5.9, 5.10) contained smaller granules which were located in 
the periphery of the cytoplasm. These cells have a small cytoplasmic to nuclear ratio and 
they were smaller in size than the Type I cells. Type I and Type II lactotropes did not 
stain for GH.
Growth hormone-immunoreactive cells possessed the largest secretory granules in 
the pituitary (Figures 5.11, 5.12). The granules were spherical in shape. Based on visual 
observation, somatotropes were medium-sized cells relative to other cells in the pituitary. 
The nuclei were generally eccentric and the cytoplasm was mostly filled with dense 
secretory granules (Figures 5.1, 5.3, 5.11, 5.13, 5.14). Epon-embedded sections revealed 
more detailed ultrastructure of the cells (5.8, 5.11, 5.13, 5.14). A few growth hormone 
secretory granules could be seen in the lumen of the Golgi apparatus (Figure 5.15).
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Figure 5.8. Type I lactotrope in an Epon-embedded pony pituitary section. Note the 
polymorphism of the secretory granules (arrow). Nucleus (N). Bar = 2 pm.
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Figure 5.9. Type H lactotrope labeled with specific primary antibody and second 
antibody conjugated to 6 nm gold particles. Note the relatively small cytoplasmic (C) 
volume and small polymorphic granules in the periphery of the cell (arrows). Adjacent 
cell is a somatotrope (*). Nucleus = N. Bar = 1 pm.
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Figure 5.10. Secretory granules in two Type II lactotropes adjacent to a somatotrope. 
Secretory granules of Type II lactotropes immunolabeled with 6 nm gold particles 
(arrows). Note the difference in the size of the secretory granules between the two cell 
types. Type II lactotropes stain exclusively for PRL. Somatotrope (S). Nucleus (N). 
Bar = 2 pm.




Figure 5.11. A somatotrope in an Epon-embedded pony pituitaiy section. The 
cytoplasm of another unknown cell type next to the somatotrope (S) contains numerous 
lysosomes (L). Nucleus (N), collagen fibers (arrows), and sinus cavity (sc). Bar = 2 pm.








Figure 5.12. Double-labeled pony pituitary section showing a somatotrope next to a 
Type I lactotrope. The somatotrope (S) is labeled with 10 nm gold particles and the 
lactotrope (L) is stained with 6 nm gold particles. Bar = .5 pm.
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Figure 5.13. Epon-embedded somatotrope in a pony pituitary section. Note the 
eccentric nucleus (N) and the homogeneous morphology of secretory granules. Bar = 3 
pm.
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Figure 5.14. Epon-embedded pony pituitary tissue at low magnification: Somatotrope 
(arrow), sinus cavity (sc), collagen fibers (arrows head). A portion of a gonadotrope (*) 
is included in the field of this micrograph. Cell of unknown type (u). Nucleus (N). Bar = 
5 pm.
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Figure 5.15. High magnification of secretory granules in the Golgi of a somatotrope 
(arrows). Bar = .5 pm.
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Double-labeling revealed the presence o f individual pituitary cells that stored both 
PRL and GH (Figure 5.7). These cells are generally known as mammosomatotropes. 
They are similar in size to somatotropes and Type I lactotropes. Granules in 
mammosomatotropes appeared similar to the large polymorphic granules in Type I 
lactotropes. Due to the similarities between mammosomatotropes and Type I 
lactotropes, it was not possible to differentiate these cells in Epon-embedded tissues. 
Double-labeling also revealed that lactotropes and somatotropes can be found next to 
each other (Figure 5.12). Different cellular junctions such as gap junctions and 
desmosomes were found between somatotropes and other cell types (Figures 5.16 A, B).
Cell Numbers and Reproductive Status of the Mares. Ovarian structures in 
the three animals included in this experiment and the plasma progesterone concentrations 
suggested that pony A was in the follicular phase, pony B was in the mid-to late luteal 
phase, and Pony C was in the early follicular phase (Table 5.1). The percentages of 
pituitary cells stained for only GH or PRL, and for both hormones are presented in Table
5.2. The numbers of cells stained for GH or PRL were 11 to 26% and 5 to 16% of total 
cells in the pituitary, respectively. Mammosomatotropes comprised about 7 to 17% of 
the total number of pituitary cells. Collectively, these three cell types, all together 
accounted for about 26 to 48% of the total number of pituitary cells counted in each 
animal.
Discussion
To our knowledge, this is the first description of the ultrastructural characteristics 
of ir-somatotropes and ir-lactotropes in the equine pituitary. These experiments
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Figure 5.16. Presence of junctional complexes in a pony pituitary. A; Desmosomes 
(arrows) between a somatotrope and a mammosomatotrope or a Type I lactotrope. Bar • 
5 pm. B: Gap junction (arrow) between two somatotropes. Bar = 1 pm.
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Right ovary Left ovary Plasma
Progesterone
(ng/ml)
A 8/3/95 20 mm follicle 40 mm follicle 1.5
B 5/4/94 45 mm follicle 
28 X 25 mm CL
40 mm follicle 33.8
C 5/4/94 25 mm follicle 12 mm follicle 2.1
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Table 5.2. Relative proportion of the GH and/or PRL containing ceils in equine anterior 
pituitaries.
Pony Total cells % G H •/•PRL •/• Both •/• Total
A 321 11.0 8.7 6.5 26.2
B 212 12.7 16.0 10.3 39.2
C 121 26.4 5.0 16.5 47.9
Average 218 16.7 9.9 11.1 37.8
Percentages are calculated by dividing the number of ir-cells by the total number of 
pituitary cells counted in a sample. Only cells with a nucleus were counted.
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demonstrate that PRL and GH antigenicity and ultrastructure were preserved when low 
concentrations of bufifered-glutaraldehyde and formaldehyde were used for tissue fixation 
and tissues are embedded at low temperature in a water miscible resin (LR Gold).
Several reports have classified lactotropes into two or three types based on 
morphology of the secretory granules and size of the cells [5.9, 5.15, 5.22]. In these 
ponies, cells which stained for PRL were distinguished into two different types based 
mainly on the size of the granules and the size of the cell itself. Type I lactotropes and 
their granules were larger than Type II cells and secretory granules in Type II cells. It 
remains to be determined whether both of these cell types actively secrete PRL or 
whether they respond differently to secretagogues or inhibitors.
An electron microscopic study done by Mikami [5.14] indicated that large 
lactotropes in the bovine pituitary gland were round or oval in shape; these cells 
contained large, dense granules, which were spherical or polymorphic. Ultrastructural 
studies by Heath [5.43] indicated that secretory granules of lactotropes in bovine 
pituitaries have the largest diameter when compared to granules in other pituitary cell 
types. Results from immunohistochemical studies of Dacheux and Dubois [5.15] with 
bovine pituitary also showed that PRL-secreting cells contained large secretory 
granules. However, these authors emphasized that the granules in lactotropes were 
smaller in diameter than the secretory granules in somatotropes. In goats [5.13], 
lactotropes contain the largest secretory granules of all pituitary cells . In equine pituitary 
glands, the secretory granules in lactotropes varied greatly in size. Nevertheless, the
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granules in equine somatotropes were the largest in size and the most uniform in shape 
compared with secretory granules in other pituitary cell types.
Storage and secretion of GH and PRL are typically considered to be a function of 
two distinct cells in the pituitary gland. However, there are reports that another cell type 
contains and secretes both hormones. In fact, 26% of cells in the pituitary of lactating 
cows contain both ir-GH and PRL [5.16, 5.17]. Thorpe et al. [5.19] reported that only 2 
out of 1800 cells counted contained both GH and PRL in sheep pituitaries. In a similar 
study, Thorpe and Wallis [5.20] cultured sheep pituitary cells and reported that 3% of the 
cells stained for both GH and PRL. However, by the end of the 96 hours of culture, 
<0.2% of the cells contained both PRL and GH. The decrease in the 
mammosomatotropic cell population was presumed to be due to cell culture or to the 
absence of hypothalamic factors necessary to maintain normal pituitary cell functions. 
Mammosomatotropes have also been found in mice [5.44], rats [5.33, 5.34, 5.45], musk 
shrews [5.45], and cows [5.33, 5.34].
There seems to be a distinct subcellular localization o f different hormones in 
granules found in ir-mammosomatotropes. The study in musk shrews and rats showed 
that there are two types of co-localization patterns for GH and PRL. In one, GH and 
PRL were packaged separately. These were found in pregnant animals. In the second 
localization pattern, both hormones are packaged in the same secretory granule [5.45]. 
Fumagalli and Zanini [5.16] reported the presence of multinucleated 
mammosomatotropes in bovine pituitary glands. These authors also reported that GH 
and PRL are packaged in three different ways, with the hormones evenly mixed together
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in the same granule, hormones found in different granules in the same cell, and with PRL 
and GH found within the same granules but segregated in different portions of the 
granule. In the present study, double-labeling demonstrated that both PRL and GH are 
evenly mixed together in one secretory granule. The mammosomatotropes comprised 6.5 
to 16.5% of the cells counted in the three different gonadally intact mares. This 
percentage is in the range reported for the incidence of cells containing both GH and PRL 
in various domesticated species [5.16, 5.17, 5.19, 5.20].
The close association of lactotropes and somatotropes and their ability to 
interconvert apparently starts early in life. Hoeffler et al. [5.46] reported on ontogeny of 
GH and PRL cells in anterior pituitary cell cultures of neonatal male and female rats and 
found that GH secreting cells are firmly established by the time PRL secretors appear 
(between day 3 and 4 of postnatal life). By performing a reverse hemolytic plaque assay, 
these authors also found that the initial PRL secretors also secreted GH. This raised the 
possibility that PRL cells could arise from GH cells during development. Similar findings 
with regard to the ontogeny of these cells have been reported in other animals including 
humans [5.27], sheep [5.47, 5.48], pigs [5.49, 5.50], and mice [5.51]. Although, these 
cells might have a common stem cell, apparently they have evolved to respond differently 
to external and internal cues.
Thompson et al. [5.52, 5.53] studied the effects of several stimuli in horses and 
reported that GH secretion is stimulated by stimulation of the sympathetic nervous 
system, treatment of the animals with TRH did not elicit a GH response, and GHRH did 
not stimulate PRL release. These researchers did not find any correlation between PRL
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and GH secretion in horses. Thus, the physiological significance of equine 
mammosomatotropes with granules containing both ir-GH and ir-PRL is not clear at the 
present time. It may be that ir-hormone detected immunocytochemically in these cells is 
not identical to radioimmunoassay hormone concentrations. However, results from 
hemolytic plaque assays of pituitary cells form other species suggests that simultaneous 
secretion of GH and PRL may occur in response to certain stimuli [5.36, 5.37].
Hemolytic plaque assays with equine pituitary cells and in situ labeling of mRNA for GH 
and PRL in equine pituitary cells would help to clarify whether ir-mammosomatotropes 
synthesize and/or secrete GH and PRL in a coordinated fashion.
In summary, the present study has confirmed that horses are similar to several 
other species in that cell populations that stain for GH and PRL can be divided into three 
types. One cell group stores both ir-hormones and the other two cell groups store a 
single ir-hormone. This basic, yet essential, information can be used to further investigate 
changes in the ratio of lactotropes and somatotropes that may occur during the 
anovulatory season. Immunocytochemistry, in situ hybridization, and hemolytic plaque 
assay can also be utilized to study the exact role of somatotropes in prepubertal and adult 
horses.
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CHAPTER VI
EFFECTS OF ESTRADI0L-17P AND DIHYDROTESTOSTERONE ON 
SOMATOTROPES AND LACTOTROPES IN EQUINE PITUITARIES:
AN IMMUNOCYTOCHEMICAL STUDY
Introduction
Boockfor et al. [6.1] utilized a reverse hemolytic plaque assay with pituitary cell 
cultures from male rats in order to provide the first direct evidence that estradiol caused a 
marked increase in the prevalence of immunoreactive (ir)-mammosomatotropes and a 
concomitant decrease in the relative proportion of cells that released growth hormone 
(GH). These authors suggested that estradiol may convert cells that release only GH to 
those that release both GH and prolactin (PRL). Other studies have shown considerable 
fluctuation in number of cells which contain GH, PRL, or both hormones throughout the 
annual reproductive cycle o f bats and musk shrews and during the transition from early 
pregnancy through the end of lactation in rats [62-6.4], Other reports [6.5, 6 .6] have 
further documented the effects of estradiol in modulating the proportion of somatotropes, 
lactotropes, and mammosomatotropes in culture or during different phases of the estrous 
cycle.
There are several reports concerning PRL secretion and storage in horses [6.7- 
6.14]. Johnson [6.7] found no change in PRL secretion throughout the estrous cycle of 
mares. Worthy et al. [6.13] reported brief increases in PRL secretion at the end of 
diestrous in three pony mares, yet these authors concluded that the exact pattern of 
plasma PRL concentrations during the estrous cycle was not clear. A study done by 
Thompson et al. [6.14] reported that treatment of ovariectomized (OVX) pony mares
132
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with estradiol increased pituitary content of PRL, but this treatment did not increase 
serum PRL concentration. These authors also reported that treatment of OVX pony 
mares with dihydrotestosterone (DHT) or testosterone increased the PRL response to 
exogenous thyrotropin releasing hormone (TRH), even though neither androgen had any 
effect on daily secretion or storage of PRL [6.14].
Results with respect to the effects of estrogens and androgens on GH are 
controversial. Hassan et al. [6.15] reported that sex steroids did not affect basal release 
of GH, but androgens increased the responsiveness of somatotropes to growth hormone- 
releasing hormone (GHRH). Other reports have shown similar effects of androgens on 
basal and GHRH-induced GH release in rats [6.1, 6.16, 6.17]. However, administration 
of testosterone to juvenile male rhesus monkeys [6.18] resulted in an increase in plasma 
PRL, pituitary PRL content, and the number of ir-lactotropes. In vivo treatment of 
primates [6.19] and in vitro treatment of sheep pituitaries [6.20] with steroids had no 
effect on GH secretion. In order to gain a better understanding of steroid effects on 
equine pituitary cells, the present study used immunocytochemistry to differentiate and 
compare somatotropes, lactotropes, and mammosomatotropes in control and steroid- 
treated OVX pony mares. Steroids tested for an effect on these cell types included 
estradiol and DHT, a nonaromatizable androgen.
Materials and Methods
Animals and Treatments. Twelve adult (6 to 12 years of age) long term (>2 
years) OVX pony mares weighing between 168 and 323 kg were kept on pasture and fed 
grass hay as needed to maintain good body condition. The mares were randomly allotted
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to one of three treatment groups (n = 4/group) which included: 1) com oil (control, 1 
ml); estradiol (Sigma Chemical Co., St. Louis. MO), 35 pg/kg bodyweight; and DHT 
(Sigma Chemical Co.), 150 pg/kg bodyweight. All injections were given subcutaneously 
in the neck region. Treatment injections were repeated daily at 0800 for 21 days.
Because of the time needed for processing tissues for electron microscopy and 
homogenization of the freshly collected tissue, one animal from each treatment group was 
started on treatment on one of four consecutive days and all animals were sacrificed on 
day 22. The experiment was performed between July 11 and August 4, 1994.
Daily blood samples were collected via jugular venipuncture immediately prior to 
the daily treatment or control injections. These samples were drawn into heparinized 
tubes; plasma was harvested by centrifugation and stored at -15“ C for later analysis.
Pituitary Preparation for Hormone Analysis. Pituitaries were removed 
within 7 to 12 min following euthanasia by electrocution. Tissues were rinsed with saline 
and cut in half, mid-sagittaly. One half was placed in ice-cold .01 M phosphate buffered 
saline (.15 M NaCl; PBS). This tissue was stripped of its surrounding capsule. The 
neural lobe was then separated from the anterior pituitary (AP) and the halved AP was 
weighed. The AP was homogenized in 100 ml of PBS in a Waring 7011 blender (Waring 
Prod. Div., Dynamics Corp. of America, New Hartford, CT) at maximum setting for 30 
sec. Another 100 ml of PBS was used to rinse out the blender. The homogenates were 
mixed well and 10 ml aliquots were centrifuged at 1200 x g for 30 min at 4“C. The 
resulting supernatants were harvested and frozen. Pituitary homogenates were diluted 
1:500 in PBS containing 0.1% gelatin. Concentration of PRL in plasma samples and GH
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and PRL in pituitary homogenates were measured by RIA as described previously [6.21, 
6.22].
Tissue Preparation for Electron Microscopy. Following a rinse with saline, 
the other half of AP was placed in freshly prepared 4% formaldehyde (Electron 
Microscopy Sciences, Fort Washington, PA) plus 0.1% glutaraldehyde (Polysciences, 
Warrington, PA) buffered with 0.1 M sodium cacodylate (pH 7.3; Electron Microscopy 
Sciences). While in the fixative, the pituitaries were freed of the surrounding capsule and 
the AP was removed from the neural lobe. The pituitary tissues were then cut into 
approximately 1 mm  ̂pieces and fixation continued for 2 h. Following fixation, ten 
randomly selected pieces from each animal were removed and cut into smaller pieces; 
these were used for embedding. Tissues were washed several times in 0.1 M sodium 
cacodylate buffer to remove any residual aldehyde. Tissues were then dehydrated in 50% 
ethanol (EtOH) for 15 min, 70% EtOH for 20 min, and 90% EtOH for 30 min. Some of 
the tissue pieces were processed for ultrastructure study using routine Epon-Araldite 
embedding for transmission electron microscopy as previously described by Poolsawat 
[6.23]. Tissues used for immunocytochemistry were infiltrated and then embedded with 
60% LR Gold (LRG; Electron Microscopy Sciences) monomer ; 40% EtOH for 30 min; 
70% LRG : 30% EtOH for 30 min; 100% LRG monomer for 2 h; 100% LRG monomer 
plus 0.1% benzil (initiator) for 2 h; and finally overnight in 100% LRG monomer plus 
initiator. All procedures were performed at room temperature. The tissues were then 
embedded in small gelatin or large BEEM* capsules (Electron Microscopy Sciences).
The LRG was polymerized under UV light at -15“ C for 24 to 36 h. Ultrathin, 80-90 nm
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light gold-colored sections were cut on a Sorvall MT2-B ultramicrotome and sections 
were mounted on 400 mesh gold grids.
Immunogold Labeling. Sections were first incubated for 10 min on a drop of 
0.05 M Tris (pH 7.3) containing 0.02 M glycine to quench any aldehyde left in the tissue. 
They were then incubated, for 30 min, on a drop of Tris buffer containing 1% BSA plus 
10% normal goat serum (blocking solution) to reduce non-specific binding. The grids 
were transferred to a 35-pl drop of the primary antibody (diluted 1:20 in the blocking 
solution). Specificity of the primary antibodies has been characterized [6.24] and 
sections in the present study were incubated with hormone-specific primary antibody- 
fi’actions for 2 h. Next, grids were blotted and rinsed four times on a drop of Tris buffer 
for 5 min each. Then the sections were blotted and transferred to a drop of the blocking 
solution for 5 min. They were then transferred to a 35-pl drop of a 20% solution (as 
recommended by the supplier) of goat anti-rabbit IgG- gold conjugate (Electron 
Microscopy Sciences) and incubated for 50 min. The sizes of the gold particles used 
were 6 or 10 nm. Single labeling was done with either 6 or 10 nm gold conjugated IgG. 
The sections were washed in Tris buffer with 2.5 M NaCl for 10 min and rinsed in 
distilled water. The final step involved incubating the sections on a drop of 0.5 % 
formaldehyde for 10 min and rinsing with distilled water followed by complete drying.
Double-labeling was done following a protocol described previously by Bendayan 
[6.25]. Briefly, following the above steps for one side of the grid, the grid was turned 
over and the same procedure was followed except that the primary antibody and the size 
of the gold particle on the secondary antibody were changed. The sections were counter­
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stained with uranyl acetate and Sato lead before examination with a Philips 410 Electron 
Microscope. Antibody specificities and cross-reactivity as well as immunocytochemistry 
controls have been reported elsewhere [6.24].
Statistical Analysis. Data consisting of repeated measurements taken over time 
were analyzed by ANOVA that accounted for the repetitive nature of blood sampling. 
Hormone concentrations in daily samples were calculated as a percentage of the 
pretreatment concentration and the least significant means (LSM) test was used to 
compare post-treatment means to 100%. Non-repetitive data were analyzed by one-way 
ANOVA; means for each treatment were compared to controls by the LSM test. All data 
were analyzed onPC-SAS [6.26].
Results
Plasma Hormone Concentrations. Pretreatment values (mean ± SB) for PRL 
were: Group 1/vehicle, 24.8 ± 20.7 ng/ml. Group 2/estradiol, 35.8 ± 34 ng/ml, and Group 
3/DHT, 41.7 ± 22.6 ng/ml. Daily PRL secretion was very variable among the three 
treatment groups (Figure 6.1). There was no overall treatment affect (P > .1) on plasma 
PRL concentrations. Due to the episodic nature of GH secretion, one daily blood sample 
would not have adequately tested any increase or decrease in GH secretion; therefore, 
blood samples were not analyzed for GH concentrations.
Hormone Content in the Pituitary. Estradiol treatment caused an eight-fold 
increase (P < .05) in pituitary PRL content compared to pituitary PRL content in the 
control and DHT-treated groups (Figure 6.2). There was no significant (P > .05)








Figure 6.1. Plasma concentrations of PRL in control and steroid-treated OVX mares. 
Mean daily concentration of PRL as a percentage of pretreatment values. Mares were 
administered oil (C), estradiol (E), and DHT daily for 21 days. Data were analyzed by 
analysis of variance. There was no significant (P > .1) effect of treatment on plasma PRL.








Figure 6.2. Pituitary content of GH and PRL in control and steroid-treated OVX mares. 
Mares were treated with oil (C), estradiol (E), or DHT daily for 21 days. For PRL, means 
with different letters were significantly (P > .1) different. There was no effect (P > .1) 
of treatment on pituitary GH content.
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difference in pituitary PRL content for the control and DHT-treated groups. Growth 
hormone content of pituitary was not affected (P > .1) by any of the treatments.
Pituitary Cell Counts. Percentages of pituitary cells containing ir-GH, ir-PRL, 
and both ir-hormones are presented in Table 6.1. Total number of cells counted in each 
treatment group were: Oil, 466; estradiol, 628; and DHT, 599. The number of ir-PRL 
cells was significantly (P < .05) higher in the estradiol- treated group. 
Mammosomatotropes were also more prevalent (P < .05) in the estradiol-treated group. 
There was no effect (P > .1) of treatment on the percentages of ir-GH cells. In the 
control group, the percentages of ir-PRL and ir-GH cells were almost equal. These cell 
types collectively accounted for about 41% to 57% of the total number of pituitary cells 
counted. Mammosomatotropes included about 3 to 6% of the total number of pituitary 
cells in control and DHT-treated mares and 10% of the pituitary cells in estradiol-treated 
mares.
Ultrastructure of Somatotropes and Lactotropes. A detailed morphological 
characteristics of ir-somatotropes (Figure 6.3), ir-Type I lactotropes (Figure 6.4), and 
mammosomatotropes (Figure 6.5) has been reported [6.24]. Results from the present 
study indicated that the ultrastructure of various cell types in OVX pony mares is similar 
to that reported for gonadally intact mares. Based on visual observations there seemed to 
be a higher number of Type II lactotropes in estradiol-treated animals compared to the 
other two treatment groups (Figure 6.6). However, Type I and Type II lactotropes were 
not counted as distinct subsets in this experiment and additional data is needed to verify 
the differences in prevalence of these cell subtypes.
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Table 6.1. Mean (M) and percentage (%) of cells stained for GH, PRL, or both 
hormones after treatment with vehicle, estradiol, or DHT.
Control Estradiol DHT
Cell types M*(%) M*(%) M* (%)
GH 25.8 (22.1)' 21.3 (13.5)' 36.8 (24.5)'
PRL 26.3 (22.5)^ 53.8 (34.2)" 20.8 (13.8)"
Both 6.8 (5.8)* 15.5 (9.9)* 4.5 (3.0) *
Total 58.9 (50.4) 90.6 (57.6) 62.1(41.3)
"Means represent average number of cells counted per grid (10 grids were counted for 
each horse).
The ± SE of the mean values for GH, PRL, and Both were 11.77, 7.67, and 2.04, 
respectively.
i,2,3,4,5 Different superscripts in each row indicates a significant (P < .05) difference within 
that row.
Percentages are calculated by dividing the number of ir-cells by the total number of 
pituitary cells counted in a sample. Total number of cells counted in each treatment 
group were; Oil, 466; E ,̂ 628; and DHT, 599.
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Figure 6.3. A somatotrope in an Epon-embedded pony pituitary section. Golgi body 
(arrow head), centriole (arrow), mitochondria (M), adjacent cell (AC), nucleus (N). Bar 
= 2 pm.
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Figure 6.4. Equine pituitary lactotrope incubated with anti-PRL and anti-GH antibodies: 
Lactotropes only stained for PRL. PRL = 10 nm immunogold, GH = 6 nm. Bar = 1 pm.
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Figure 6.5. Epon-embedded mammosomatotrope in a pony pituitary section. Note the 
polymorphic granules (small arrows). Golgi body (arrow head), centriole (large arrow), 
nucleus (N). Bar = 1.5 pm.
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Figure 6.6 . A cluster of Type II lactotropes in the pituitary of an OVX pony treated with 
estradiol. Bar = 5 pm.
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Discussion
Treatment of OVX ponies with estradiol caused a significant increase in cells 
stained for ir-PRL. Estradiol treatment also increased the total amount of PRL in the 
pituitary. At the same time, the proportion of cells that stained for both PRL and GH 
was increased by estradiol treatment. The increase in pituitary PRL and ir-cells which 
stained for PRL (lactotropes and mammosomatotropes) in estradiol-treated mares was 
not reflected in an increase in plasma PRL concentrations. Stratmann et al. [6.27] 
reported that following 21-day treatment of rats with estradiol there was a true 
transformation of somatotropes to lactotropes. Later, Nogami [6.28] also showed that 
stimulation of newborn and adult rats with estradiol resulted in an increase in lactotrope 
populations. Finally, Frawley et al. [6.29] reported the presence of a distinct cell 
population in the pituitary that is capable of secreting both GH and PRL concomitantly, 
hence, these cells were referred to as mammosomatotropes. Later on, studies from the 
same laboratory showed that the fluctuation in number of lactotropes and somatotropes is 
influenced by gonadal steroids [6.5, 6.6] and that there is a bi-directional interconversion 
of these two cell types which depends upon hormonal cues [6.5]. Our study of pony 
pituitaries tends to support the conclusion that numbers of ir-lactotropes and 
somatotropes were affected by steroids and that there may be transdifferentiation [6.30, 
6.31] of lactotropes and somatotropes. The augmentation in the total 
mammosomatotrope cell group in estradiol-treated mares could reflect cell division in the 
pituitary. This possibility was examined by Kineman et al. [6.31] where bovine pituitary 
cell cultures were subjected to several stimuli followed by reverse hemolytic plaque assay.
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The results from that study indicated that acidophilic subpopulations of pituitary cells are 
capable of transdifrerentiation and no significant cell division was involved. However, 
the authors reported that estradiol was incapable of increasing PRL in their culture 
system.
Thompson et al [6.14] reported a stimulatory effect of estradiol on storage of 
PRL. Yet, when challenged with TRH, there was no increase in PRL levels in the blood. 
In an experiment where the morphological characteristics of lactotropes and 
somatotropes were studied, we reported [6.25] that there are two distinct populations of 
lactotropes in the equine pituitary. Type I and Type H. Type I cells were characterized as 
being larger than Type H cells and they contained numerous large polymorphic secretory 
granules. Type II cells were smaller in size and had a large nucleus to cytoplasm ratio, 
and relatively small peripherally located secretory granules. In this study, based on visual 
observation, it appeared that there were more Type II lactotropes than Type I lactotropes 
in the estradiol-treated group whereas the proportion of these subsets of cells seemed to 
be equal in control OVX mares. Since a relative increase in plasma PRL concentration 
was not detected in this study it is a possible that these cells are not responsive to the 
secretagogues. This possibility is supported by experiments that did not detect a 
stimulatory affect of TRH on plasma PRL in OVX pony mares treated with estradiol for 
21 days [6.14].
Estradiol effects on somatotropes are controversial and seem to be species- 
specific. In estradiol-treated rat pituitary cultures, Simard et al. [6.32] reported a 2- to 3- 
fold increase in GH release as well as the cellular GH content. Bethea and Freesh [6.33]
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and Copeland et al. [6.19] reported that physiological doses of estradiol do not stimulate 
GH release in primates. However, Herbert [6.18] reported that administration of 
testosterone to juvenile male rhesus monkeys resulted in an increase in plasma PRL, 
pituitary PRL content, and the number of lactotropes. Our experiment with ponies did 
not detect an effect of estradiol on pituitary content of GH or the number of 
somatotropes. Kineman et al. [6.5] also reported that the relative proportion of 
somatotropes remained unchanged throughout the bovine estrous cycle.
Treatment of the OVX pony mares with DHT did not have any effect on plasma 
PRL concentrations. Treatment of OVX pony mares with androgens, and a subsequent 
challenge with TRH has been reported to increase plasma PRL concentrations [6.14]. 
Apparently androgens enhance the sensitivity of the PRL response to TRH. The lack of 
stimulatory effect of DHT on basal PRL secretion in this study was in agreement with 
the previous study [6.14]. Nogami [6.28] reported that testosterone administration to 
male rats decreased PRL secretion, whereas androgen treatment of juvenile monkeys 
caused an increase in pituitary PRL content and the number of PRL secreting cells [6.16]. 
Thus, androgen effects on basal plasma PRL concentrations and numbers of ir- 
lactotropes may be subject to species differences.
The exact role of GH and factors that might influence its secretion, storage, and 
release in the horse has not been thoroughly investigated. However, our laboratory has 
conducted a series of experiments to characterize the pattern of GH secretion and affects 
of various stimuli on GH secretion in horses [6.22, 6.34]. The findings from those 
experiments were that GH secretion is pulsatile in nature, the GH response to growth
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hormone-releasing hormone (GHRH) was greater in stallions than in mares and geldings, 
acute physical exercise and exposure to an estrual mare increased plasma GH 
concentration, pharmacological inhibitors and/or stimuli for PRL secretion did not have 
any affect on GH, and GH levels were higher in males than in females. In this study,
DHT treatment did not affect pituitary content of GH or the relative proportion of 
pituitary cells that stained only for GH. Testosterone has been shown to promote storage 
of GH in the pituitary of rats [6.35, 6.36] and increase the pituitary responsiveness to 
GHRH [6.17]. Our findings in the equine species are in agreement with other studies in 
that estradiol has a stimulatory effect on PRL and this is manifested at the pituitary level 
by increased pituitary content of PRL and increase numbers of pituitary cells which stain 
for PRL. Gonadal steroids do not seem to have any effect on GH content of the pituitary 
and the ratio of the three cell types described.
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CHAPTER V n  
OVERALL SUMMARY AND CONCLUSIONS
The results from experiments included in this project demonstrate that fixation of 
equine pituitary tissues in cocadylate-bufrered 4% formaldehyde with 0.1% 
glutaraldehyde followed by low temperature embedding in a water miscible resin resulted 
in ultrastructural preservation of the organelles and cell membranes. This approach also 
allowed for preservation of the antigens (hormones) in secretory granules, as was 
indicated by specific binding of the primary antibody preparations and gold-conjugated 
secondary antibodies. Our results agreed with the results of other researchers who have 
used a variety of species, in that the concept of exclusive “one-cell:one-hormone” 
producing cell types does not apply to certain subtypes of equine pituitary cells. Further, 
results from experiments described in Chapters in and V demonstrate that the 
ultrastructure and immunoreactivity of various subsets of equine pituitary cells are 
comparable to that described in most of the literature for other mammalian species. The 
findings form experiments described in Chapters IV and VI demonstrated the steroids 
may affect subsets of equine pituitary cells. These experiments also demonstrated that 
steroid treatment of OVX pony mares may affect the amount of ir-hormone in selected 
pituitary subset of cells, reciprocal transdifferentiation of the pituitaiy cells, and/or the 
total number of ir-cells as a percentage of the hormone-specific and chromophobic cells 
in the pituitary. These data collectively provide the basic information needed to conduct 
future studies on effects of exogenous treatments and physiological changes in specific 
subsets of equine pituitary cells.
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